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Abstract

Delirium is a complex syndrome resulting from compounding effects of acute illness,
comorbidities, and environment. It results in adverse outcomes: elevated mortality rates, length
of stay, readmissions, institutionalization, long-term cognitive changes, and diminished quality
of life. The rates of iatrogenic delirium are astounding, ranging from 10%-89%. There are no
curative treatments; thus, primary prevention is the key. The purpose of this literature review is
to identify and critique the research for accuracy of risk stratification and feasibility in practice.
Support for interventions that prevent delirium is mounting; however, interventions are resourceintensive and often not implemented. Researchers have responded to this problem by developing
risk stratification tools to triage interventions toward those of the highest risk. There is evidence
that some of the models' implementation is successful; however, they are not yet widely
operationalized. A compilation of seven published models of risk prediction were critiqued and
compared using the Stetler Model of Evidence-Based Practice as a guiding model. The
Newcastle-Ottawa Scale and the Critical Appraisal and the Data Extraction for Systematic
Reviews of Prediction Modelling Studies (CHARMS checklist) are employed to aid in the
critical appraisal, evaluation of the study's quality, and aid in data abstraction. The models show
the ability to stratify risk, but their effectiveness in practice cannot be studied without directed
interventions because they risk prediction models are created to aid healthcare staff in making
clinical decisions. Therefore, a complete clinical pathway with evidence-based interventions
should be employed with a delirium risk prediction model to triage the interventions to patients

at the highest risk. Recommendations are to implement an automated electronic model
(automatic calculation using the EMR or a machine learning model) into clinical practice along
with a delirium prevention care pathway. Electronic versions of risk scores allow for an
opportunity to achievement clinical efficiency and show statistical superiority to the other
models. Published evidence on the impact of the models is diminutive, their ability to triage
patients and aid in clinical decision-making should be published in an impact study.
Keywords: Delirium, risk assessment, risk prediction, risk model, risk score, patient safety,
patient-centered outcomes research.
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Introduction

According to the Diagnostic and Statistical Manual 5th Edition (DSM-5), delirium is an
acute cognitive change resulting in an alteration in cerebral functionality of the brain, and its
severity fluctuates over a short period (American Psychiatric Association [APA], 2013).
Delirium is a medical emergency indicating the presence of a severe underlying illness resulting
from a complex compilation of predisposing and precipitating factors that are at the root of its
onset (Wass, Webster, & Nair, 2018). Its hallmark signs are disturbances in awareness,
attention, and perception. The negative consequences of delirium are far-reaching, impacting the
patients, families, healthcare staff, hospitals, and healthcare systems. Those with delirium are at a
higher risk of morbidity, mortality, postoperative complications, prolonged length of stay,
readmissions, institutionalization, and long-term cognitive changes resulting in a diminished
quality of life (Douglas et al., 2013; Inouye et al., 1993; Rudolph et al., 2011).
In acute care settings delirium is the single most common acute disorder affecting aged
(Carrasco et al., 2014; Health Research and Education Trust [HRET], 2018; & Inouye, 2018). It
affects 10% to 20% of all hospitalized adults (over 18 years of age), 14% to 56% of all
hospitalized patients aged 60 and over, 42% in the general medical settings (Carrasco, Villarroel,
Andrade, Calderon, & Gonzalez, 2014), and up to 89% of patients admitted to an intensive care
unit (ICU) (Hayhurst, Pandharipande & Hughes, 2016; HRET, 2018).
Preventative Interventions
Studies show that multifactorial and interdisciplinary interventions result in an overall
reduction in delirium rates between 30% (Brown et al., 2017) and 53% (Halladay, Sillner, &
Rudolph, 2018; Inouye et al., 1999; Wong et al., 2018). The interventions focus on early and
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frequent mobilization, promotion of a healthy circadian rhythm, adequate hydration, urinary and
fecal continence, reorientation to place, time, and situation, therapeutic activities (walking,
watching tv, listening to music, playing cards, folding towels, or engaging in self-care), use of
glasses and hearing aids or devices other sensory devices, anesthesia protocols (sedation
medications to avoid and minimization of sedation levels), prompt removal of intravenous (IV)
lines, drains, and restraints, nutritional optimization, and “non-pharmacologic” sleep promotion
interventions, and pharmacist involvement in decreasing use of medications associated with
delirium development (Douglas et al., 2013; HRET, 2018; Hospital Elder Life Program [HELP],
2013; Inouye et al., 1999; National Institute for Health and Care Excellence [NICE], 2010;
Reston & Schoelles, 2013). The implementation of the interventions requires a clinician to
recognize and prioritize the prevention of delirium; however, during acute hospitalizations, cooccurring illnesses often take precedence over delirium risk (Taft, Nelsen, Slager, & Weir,
2018).
Guideline and Societal Recommendations for Risk Determination
There is no known cure for delirium; thus, its management of a delirious patient includes:
treating the potential causes (precipitating factors), supportive care during recovery, and, when
necessary, the pharmacological treatment for behavioral symptoms (Michaud et al., 2007). NICE
published a guideline for delirium recognition and management recommending that all adults at
risk for delirium should receive tailored interventions to prevent the iatrogenic onset (NICE,
2014); they list risk factors for delirium but do not suggest a systematic method to determine
risk. In response to the need for a systematic method, the HRET proposed that all healthcare
facilities employ a risk prediction model to identify patients at high risk for the development of
delirium (HRET, 2018). In an effort to remedy the gaps in delirium prevention innovative
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researchers have been prompted to develop delirium risk prediction models. Individual
healthcare systems may have also developed methods to systematically stratify the risk of
delirium and provide guidance on interventions to implement based on the risk level. This
author located two published models that are implemented into clinical practice within two
healthcare systems (Douglas et al., 2013; Rudolph, Doherty, Kelly, Driver, & Archambault,
2016).
Introduction to Delirium Risk Prediction Models
Despite the high rates of hospital delirium and its adverse effects on a patient, family, and
healthcare system, delirium risk prediction models rarely are adopted into practice. The reasons
that delirium risk prediction models are not employed include a lack of consensus on the causes
and pathophysiology, which model to use in which situation, the timing of the assessment, the
accuracy of the current models in clinical settings, as well as the fact that the guidelines are not
recommending one model over another (Newman et al., 2015; Wang et al., 2017).
The first delirium risk prediction model (DRPM) was developed in 1993 by Dr. Inouye
and colleagues, using a dual prospective cohort study approach, in tandem, to develop and
validate a risk prediction model (Inouye et al., 1993). This model was never widely adopted into
practice due to the required acute physiologic and chronic health evaluation scoring that created
a necessity to draw additional laboratory sample (arterial blood gas). Some models rely on
questionnaires administered by health care professionals making integration into clinical practice
impractical. Usability in clinical practice is a requirement and includes accuracy of risk
stratification, ease of use, and timeliness. In an external validation study by Pendlebury (2016a)
found that DRPMs must be adapted and simplified to allow for use of routinely collected clinical
assessments (Wong et al., 2018).
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Delirium risk prediction models are developed to allow healthcare providers to target
high-risk individuals to increase delirium screening assessments and implement targeted delirium
prevention interventions. Assessing risk is not a new concept to healthcare; however, it is
becoming more commonly used by healthcare providers to aid in the decision-making process
when resources are limited, or risk of illness decreases by the implementation of interventions
appropriate to the clinical question. Delirium is a complex, iatrogenic syndrome caused by
numerous predisposing and precipitating factors. The use of clinical and technologically
advanced prediction models may allow for triaging of resource-intensive interventions that make
delirium preventable. Risk prediction models are most useful in situations such as delirium
when the outcome is difficult to ascertain due to the immensity of causative factors.
Background
Despite early management and treatment of incident delirium it may result in
considerable consequences for the patients and health care systems. Increased mortality rates
during and post hospitalization, an average of eight days prolonged hospital stay, increased risk
of complications, poor physical recovery and cognitive recovery, increased risk of development
of dementia, and higher chance of placement in a residential care facility after discharge. Frailty
prior to delirium and delays in diagnosis and treatment increase the odds of the occurrence of
these negative outcomes.
Delirium carries an in hospital mortality risk of up to 75% whilst in the hospital and after
discharge 40% in the first year (Wass et al., 2018). Delirium has devastating consequences that
have domino effects for the patient, family, healthcare system, and the population in general.
According to LaHue et al. (2019), iatrogenic delirium is significantly associated with hospital
readmissions within 30 days of initial discharge with an odds ratio (OR) of 2.60 (95% CI: 1.96-
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3.44), as well as post-discharge emergency room visits within 30 days of discharge OR: 2.18
(95% CI: 1.77-2.69). Medicare and Medicaid impose penalties on hospitals with elevated 30-day
readmission rates; thus, there is a national effort to decrease readmissions rates (LaHue et al.,
2019) thus preventing delirium as part of this effort seems necessary.
The cost of hospitalization for patients with delirium increase by $16,303 to $64,421 per
patient (Leslie, Marcantonio, Zhang, Leo-Summers, & Inouye, 2008) resulting in $38 billion to
$352 billion annually (Douglas et al., 2013). Less than half of patients fully recover before
discharge, which incurs additional costs associated with residential care, rehabilitation, and home
services (Wass et al., 2018). The 2050 projections on aging note that 88.5 million people will be
over the age of 65, which is more than double that in the year 2010 (U S Census Bureau, 2010).
Individuals over 65 are at a higher risk for developing delirium (Douglas et al., 2013) since most
have multiple predisposing risk factors (male gender, history of cognitive impairment, renal
disease, liver disease, cancer) and in general, are increasingly vulnerable to insults when multiple
risk factors are present, or illness is severe (Wass, et al., 2018). Without actions to curb the rates
of delirium, incidence and consequences will continue to impact patients and the financial
burden will increase as the elderly population explodes.
Manifestations of Delirium
Delirium can affect an individual’s ability to rest, wake, converse, and their awareness of
surroundings. It alters a patient’s ability to reasoning resulting in agitation, hallucinations, or
delusions (Ford, 2016). The most frequently observed symptom is moderate to severe
inattention most often detected during a physical exam; elicitation of mild inattention could
require a formal cognitive test (e.g., digit span, serial sevens, or naming the months in reverse
order) (Cerejeira, & Mukaetova-Ladinska, 2011). This syndrome can manifest clinically on the
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three domains: cognitive, executive, and circadian rhythm disturbances (Thurber et al., 2015).
An individual’s disorientation, memory impairment, and inattention demonstrate cognitive
effects. Executive functioning deficits show in a patient's inability to complete a task or thought,
difficulty with self-regulation of behavior, impaired ability to interact socially, changes in
speaking ability and speech patterns, and inability to problem solve. Circadian rhythm
disturbances result in disturbed sleep-wake cycles, often reversed into insomnia at night with
fatigue or exhaustion during the daylight hours.
Three subtypes can categorize delirium; hyperactive, hypoactive, or mixed with both
hyperactive and hypoactive features. Hyperactive types are the most recognized by healthcare
providers, as it presents with agitation, emotionally lability, restlessness, sleeplessness, and are
potentially combative behaviors (Vasilevskis, Pandharipande, Girard, & Ely, 2010). This subtype
often requires increasing nursing interventions with frequent calls to physicians for medical or
pharmacological interventions; to manage aggressive, unsafe patient behaviors, and providing
safety for the staff caring for these patients. Hyperactive delirium is much more involved
concerning behavioral issues, and these patients are likely to need restraints or chemical sedation
with medications such as Haloperidol or Lorazepam.
Hypoactive delirium is the most serious of all subtypes; patients characterized by apathy,
decreased responsiveness defined as lethargy, unresponsiveness, or coma. These patients are
typically older than 75 years of age, have many co-morbidities, and present with greater severity
of illness (Cerejeira & Mukaetova-Ladinska, 2011). It is the most under-recognized, undertreated subtype (Vasilevskis, Ely et al., 2010), and is likely to be overlooked and misdiagnosed
as either depression or fatigue (Cerejeira & Mukaetova-Ladinska, 2011). Evidence indicates a
poorer prognosis in patients with the hypoactive type of delirium; this is perhaps due to the poor
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recognition and treatment or the immobility associated with this subtype (Vasilevskis et al.,
2010).
Mixed hyperactive/hypoactive delirium is the subtype in which patients alternate between
lethargy and hyperactivity. This combination type is unlikely to be the most commonly
diagnosed because a patient may be misdiagnosed with “sundowners” during periods of
hyperactivity. In a study of the prognostic effects of these motor types, Avelino-Silva, Campora,
Curiati, and Jacob-Filho (2018) state, “hypoactive delirium was the predominant motor subtype
(53%), followed by mixed delirium (30%) and hyperactive delirium (17%). Hospital mortality
rates were respectively 33%, 34%, and 15%” (2018, p. 1). This study also noted that hypoactive
delirium had an independent hazard ratio for in-hospital mortality of 2.43 (95%CI =1.64–3.59)
and mixed delirium resulted in a hazard ratio for in-hospital mortality of 2.31 (95%CI = 1.53–
3.50) (Avelino-Silva et al., 2018, p. 2).
Understanding the manifestations, subtypes, and the implications of them can aid
healthcare providers in recognizing its subtle or not so subtle onset. Recognition of delirium
improves with the implementation of assessment tools for the onset of delirium in practice
(Inouye et al., 1993). These may include tools such as the confusion assessment method (CAM),
the nursing delirium screening tool (NuDeSC), the delirium observation screening scale (DOSS).
Pathophysiology
Due to complexity of physiologic responses to illness and injury, the pathophysiology of
delirium is poorly understood and rarely researched (MacLullich, Ferguson, Miller, de Rooij, &
Cunningham, 2008). MacLullich et al., (2008) proposed two very distinctive classifications of
etiologies of delirium. The first are direct brain insults such as trauma, intracranial hemorrhages,
cerebral infarcts, hypoxemia, hypercapnia, and hypoglycemia. The second are “aberrant stress
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responses” which result from normal protective functions of the human body in response to
infections, surgeries, anxiety, and pain (MacLullich et al., 2008). This stress-diathesis model is
dominant in literature stating the interaction of predisposing factors and the adequate or
inadequate stress response (Newman et al., 2015). Elevated levels of dopamine, impaired
acetylcholine synthesis and cholinergic synapses, low levels of norepinephrine, 5hydroxytryptamine, and y-aminobutyric acid result (Wang, Lyu, Tan, Wang, & Liu, 2017).
Wang et al. (2017) also report that the insults driven by the external factors (surgery, trauma, and
infection) active the vascular endothelial cells causing destruction of the blood-brain barrier
which allows the inflammatory factors to cross into the cerebral tissues, stimulating further
release of proinflammatory factors and ultimately resulting in neurotoxicity and delirium. Thus,
delirium should not be regarded as a psychological issue, instead it should be prevented and
managed comparably to other diseases (MacLullich et al., 2008; Wang et al., 2017).
Predisposing and Precipitating Factors
Recognizing the risk of delirium currently hinges on a clinician’s or nurse’s ability to
effectively assess patients for predisposing and precipitating factors and using clinical
judgement decide if a patient is at risk. Based on past experience and education of a clinician or
nurse preventative measures may be implemented. Predisposing risk factors are those that
describe the vulnerabilities of the individual, which are non-modifiable. Precipitating factors are
events that occur with illness or within the healthcare facility, that trigger delirium, which may
be modifiable.
According to Mehta et al. (2015), the predisposing factors of significant importance are
age, history of cognitive impairment (dementia or a history of delirium), and sensory
impairments. The precipitating factors are severity of illness, administration of opioids,
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benzodiazepines, antipsychotics, oral analgesics, anticholinergic, and sedatives (Mehta et al.,
2015). According to the NICE guideline, the precipitating risk factors are acute infection,
fracture, emotional or physical stress, surgery or other medical procedures that include
anesthesia, pain, sedatives, hypnotic medications, anticholinergics, anemia or blood loss,
dehydration, malnutrition, and electrolyte disturbances (NICE, 2010). Precipitating factors
include hospital environments, particularly in the ICU, where frequent disruptions disrupt the
circadian rhythm. Over one hundred various triggering events are associated with delirium in the
ICU alone (Vasilevskis, Pandharipande et al., 2010). Each source and organization vary in their
lists of these risk factors and each risk prediction model vary in the risk factors used and how
they are weighted in relative importance. Tables 1-7 show the models with their risk factors
including the modified tools by Pendlebury et al. in their model update study (2016a).
Groves and Huskin (2011) believe that baseline risk is a predictor of delirium likelihood,
and when a patient has a low baseline risk, despite triggering events, their likelihood of
becoming delirious is low. However, if vulnerabilities are high and baseline risk is
High (many or complex comorbidities or severity of illness), then delirium may occur even with
the most innocuous of insults.
The consensus is still out as researchers continue to evaluate the relationships between
the predisposing and precipitating factors and other newer findings such as biochemical,
environmental, and genetic factors. In all accounts, delirium is a result of the complex
interactions of both predisposing and precipitating factors (Inouye, 2018; Rudolph et al., 2011)
as well as the individual's status of baseline protective mechanisms (Groves & Huskin, 2011).
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Risk Stratification or Prediction Models
Risk stratification is a technique for systematically categorizing patient risk levels based
on their health status, predisposing, and precipitating factors. Clinical risk prediction models
(also known as risk prediction rules, stratification tools or models, risk assessment models, risk
decision rules, risk scores, risk assessment tools, and indexes) are tools that can determine the
probability of an event occurring. Healthcare risk prediction or stratification models are essential
for optimizing of healthcare research, quality improvement, and clinical decision-making
(Bernard, 2017).
Assessing risk is not a new concept to healthcare. It is becoming more common as
healthcare resources are increasingly limited. Implementation of risk assessment tools are
successful in the stratification of other complex medical situations such as the risk of falls
(Hendrich II), pressure sores (Braden scale), stroke risk in patients with atrial fibrillation
(CHA₂DS₂-VASc), osteoporosis fracture risk assessment tool (FRAX), and the 10-year heart
disease risk score (atherosclerotic cardiovascular disease (ASCVD)). The National Institute of
Health (NIH) and Patient-Centered Outcomes Research initiatives (PCORI) support risk
prediction tools used to personalize an individuals’ healthcare needs in a personalized dynamic
manner (Columbia University Mailman School of Public Health, 2019). Risk stratification
allows for customized medicine with an emphasis on specific treatments (Agyeman & OforiAsenso, 2015) before any symptoms occur to diminish the risk of illness. Delirium biomarker
research is a growing and expanding area of study. Presently there is no biomarker test to
determine the presence or the risk for delirium. Some of the previously mentioned risk prediction
models incorporate biomarkers or medical technology in their scores. The lack of this technology
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for the diagnosis of delirium makes its prediction more complicated than the prediction of other
conditions.
Organizations proposing ways to identify people at risk for delirium include the
American Nurses Association (acronym) (American Nurses Association [ANA], 2016), the
HELP (lists of risk factors) (2013), HRET (2018), and the NICE Guidelines (2010) for the
prevention of delirium (lists of risk factors). These organizations have websites that are integral
for clinical practice for updates on delirium, including its prevention and management (Table 8).
Due to the high mortality, morbidity, cost of care, and impact on patients that develop
delirium and the health systems that care for them, evaluation of existing DRPMs must be done.
Researchers continue to create models, but what is lacking are studies on impact,
implementation, and quality improvement. Nurses are a key to the assessment and appraisal of
these models because they are at the bedside caring for the delirious patients. They aid in the
implementation of risk assessments and the interventions aimed to prevent this syndrome.
Nurses additionally are involved in quality improvement projects. Guidelines state healthcare
providers need to assess for risk but do not currently recommend a DRPM or any other
systematic method to stratify risk.
Purpose
The purpose of this integrative literature review is to identify and critique the research on
delirium risk prediction models for adults admitted to general medical units. Recommendations
for assessing delirium risk in clinical practice are outlined.
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Clinical Nursing Questions
The following clinical nursing questions were developed to guide the literature review.
Do the validated primary delirium risk prediction model studies: (a) support their claim of
feasibly in practice, (b) show accuracy and (c) ability to stratify the risk of delirium development
in the general medical hospital population?
Method of Inquiry
A systematic literature search was completed using the methods outlined by the Winona
State University Library (n.d.). It is a five-step approach to provide the seeker with relevant
articles that will provide information to aid with clinical practice or research. A five-step method
provides a simplistic approach for structuring the inquiry and gathering of the literature. The
five steps are:
Define the project by refining a question and brainstorm related ideas to develop a list of
key terms
Complete a preliminary search
Refine the focus and look for quality articles
Arrange the ideas in groupings and synthesize the literature
Write chapters or sections, placing the literature within each, noting the gaps (Winona
State University Library, n.d.).
Literature Review
The following sections are a comprehensive review of the literature including a synthesis
and analysis of the research findings. Current practices in delirium risk prediction, risk factors
for each model, statistical significance of each of the eight delirium risk prediction models, their
capacity to stratify those at high risk accurately, and the ease of use of each model will be
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discussed. The studies were included based on their level of evidence, as defined by Ackley,
Swan, Ladwig, and Tucker (2008). The studies were appraised by use of the Newcastle Ottawa
Scale for Quality Assessment which aided in determining the quality of study (Table 9). The
levels of evidence description are located in table 10 and a table 11 was created to show the level
of evidence for each DRPM included in this review. The Stetler model of research utilization
(2001) is explained as a model for completion of this literature review. To highlight and clarify
the contents of each DRPM and how they were scored (tables 1-7).
Search Strategy
To identify the primary studies of DRPMs using clinical data to predict iatrogenic
delirium an extensive search was completed. Guided by the Methodological recommendations
described by the Winona State University Library, the clinical questions guided the search.
Cumulative index to nursing and allied health literature (CIHNAL), PubMed, PsychINFO, and
the Cochrane library databases were searched using variations in keywords “delirium” or “acute
confusional state” with Boolean connections to “rates”, “treatments”, “differential diagnosis”,
“workup”, “predictors”, “pathophysiology”, “causation”, “cost”, “impact on families”, and/or
“impact on patients”. These articles added background knowledge and support to this project
and are referenced throughout the paper.
A second exploration was then completed within the same databases to narrow the
discovery to stratification models which included multiple combinations of the following terms;
“delirium” or “acute confusional state” or “acute confusion” or “acute brain dysfunction” and
“risk assessment” or “tools” or “models” or “predict*” or “risk screen*” or “risk stratification” or
“risk prediction” and “acute care”, “general medicine” or “medical” or “hospital admission” or
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“hospital*”. Exclusions included “alcohol” or “drugs” or “withdrawal” or “ICU” or “fracture” or
“surgery”.
Further addition of the subject matter was obtained by a third search focused to answer
the questions in this review by using ‘One Search’ from the Winona State University Library.
This search strategy allowed for an expansive search of many databases in less time since it pulls
together all the library’s resources into one single search. This search provided most of the
articles included in this review. The search was limited to peer-reviewed literature; articles,
dissertations, Journals; the English language, publish dates of 2008-2018 (to ensure the most up
to date evidence was gathered), adults, older people, geriatrics, aged-medicine, hospitals, and
medicine with the main subject of delirium. Titles of articles were reviewed for the keywords
delirium or acute confusional state (required) and risk assessment, risk tools, risk scores, risk
models, or risk stratification. Next the abstracts for the articles of interest were read, further
narrowing the studies to fit the clinical questions. After reviewing the abstracts, studies of
interest were saved for a full review. When a full-text article was not available online it was
requested through the Winona State University library.
A review of full articles revealed further narrowing of the subject was needed to focus on
general medical admissions because there were many models created for specific areas of the
hospital or clinical condition such as post-cardiac surgery or orthopedic surgery, or
ischemic/hemorrhagic stroke focus. Tools that predicted only prevalent delirium were
disregarded, keeping the focus on obtaining studies on DRPMs created to determine the risk of
incident or iatrogenic delirium (occurring after hospitalization).
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Search for Recommendations of Statistical Cut-off Points
Information was sought, to aid in determining ideal AUC cut-off points for the accuracy
of the risk stratification models. The literature showed that risk stratification models differ from
diagnostic models in that the accuracy in diagnosing is not the goal of prediction modeling.
Instead, they are created to rule out low risk people and limit expended resources by triaging
people by the level of risk. An accurate prediction model may limit the resources to 50% of the
population or less without false negatives. The most popular statistics of a predictive model is
the receiver operating characteristic (ROC) curve which is a plot of sensitivity (Se) and
specificity (Sp) (Cook, 2008). The ROC or area under the curve (AUC) can also be called a cstatistic or c index. According to Lee, Bang, and Kim (2016), a model with an AUC of 0.50-0.59
has poor discrimination power, an AUC of 0.60-0.69 has better than average power to
discriminate, an AUC of 0.70-0.80 has adequate power of discrimination, and 0.80-0.90 is
excellent (Lee, Bang, & Kim, 2016).
The following statistical levels are employed based on the previous recommendations and
the evidence in the statistical models: a poor performance rating occurs when the AUC, ROC, or
c-statistic are between 0.50 and 0.59 (as this indicates the model is stratifying risk lightly better
than a coin toss), moderate performance is between 0.60-0.75, and excellent performance is
between 0.76-1.0. Studies of poor performance (≤0.59) were not included in this review as they
lack statistical significance. The range of AUC in this review is 0.69-0.85, thus all are proven to
have moderate or better performance.
A total of fourteen models were discovered and are presented in the literature review
table (table 12). During the process of the literature review seven of the studies were not
validated internally or externally. According to the literature on risk prediction models

16

validation of a model equates to proof of its applicability in a clinical setting. Validation of a
model can be internal (use of the same data set for development and validation of the model),
temporal (model validation on subsequent patients from the same facility), or external validation
(model validation in a different facility with a similar population). Validation of a study proves
or disproves its clinical credibility, accuracy, generalizability, and preferably shows clinical
effectiveness (Altman et al., 2009). The unvalidated studies are relevant to the future of delirium
risk prediction, thus were retained within the literature review tables (Table 12). The seven
models critiqued are marked by an asterisks before the first authors name in the literature review
tables.
Appraisal and Synthesis of Evidence
The highest levels of evidence attainable are randomized controlled trials (RCT) or metaanalysis to answer clinical questions related to the primary prevention of illness. Next in order of
the hierarchy are prospective studies, cohort studies, case-control studies, and case series
(Ackley, et al. 2008). The level V studies include the highest level of evidence for systematic
reviews of qualitative studies such as a meta-synthesis or an RCT (Ackley et al., 2008). Three
studies, that are rated as level V evidence, were found and included in this review which are:
Models for predicting incident delirium in hospitalized older adults: A systematic review by
Kalimisetty, S., Wajih, Fay, & Khan, (2017); Systematic review of prediction models for
delirium in the older adult inpatient by Lindroth, et al., (2018); and Predicting delirium: a
review of risk-stratification models by Newman, O'Dwyer, & Rosenthal, (2015). One systematic
review of delirium risk prediction models focused on understanding the barriers to
implementation (Newman, O’Dwyer, & Rosenthal, 2015). The aim of the systematic review by
Kalimisetty et al., was to develop a risk prediction model based on the reported risk factors in
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current models (Kalimisetty, Wajih, Fay, and Khan, 2017). A third study aimed to recommend
the study design for future development of delirium risk prediction models (Lindroth et al.,
2018). Each of these studies contributed to background knowledge and aided in the
identification of understanding of DRPMs.
The seven validated DRPM studies selected for this review were representative of level
IV studies. The Kobayashi et al., 2013 and Wong et al, 2018 studies being retrospective cohort
designs, and the other five are prospective cohort designs. Five of the studies were completed in
individual university healthcare centers, one was conducted in two locations of a university
hospital and validated at a Veterans Administration (VA) medical center. The final one was
conducted at 118 VA system hospitals. The least number of participants in the studies was 100
patients and the most was 27,625 (Wong et al., 2018) with the median participant number at 308.
All studies lacked randomization and control of variables. The definition of level of evidence can
again be viewed in Table 11.
Appraisal and quality assessment cannot be completed with the use of tools created for
systematic reviews, diagnostic studies, prognostic studies, RTCs, or qualitative studies.
Discovery of the Newcastle Ottawa scale (NOS) allowed for the evaluation of the prediction
models study quality. Critical Appraisal and Data Extraction for Systematic Reviews of
Prediction Modelling Studies (CHARMS Checklist) provided a method to appraise these primary
prediction model studies.
Newcastle-Ottawa Scale (NOS)
The quality of cohort and case-control studies can be assessed using the NewcastleOttawa Scale (NOS). It was developed to provide an instrument of ease for evaluating nonrandomized cohort or case control studies to be used in systematic reviews (Peterson, et al.,
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2011). There are not specific quality instruments for evaluation of prediction studies. Criteria
included in this tool are selection of the study groups, comparability of the groups; and the
outcome of interest for the studies and are rated based on a star system. The NOS aided assessing
the quality of the studies and the creation of a comparative study table to outline relevant data
from each risk assessment tool (Table 10). Newman et al. (2015) used the NOS in their
systematic review noting two of the scale assessments were irrelevant to the DRPM studies. In
the selection section it asks if the case definition is adequate, defined by the study being
independently validated in a similar population, however, significant baseline differences are a
study strength in prediction model validation, as this shows generalizability of a prediction
model (Newman et al., 2015). There are no interventions employed in the research papers thus
follow up of patients was not needed, therefore, ‘adequate follow up after an intervention was
employed’ was also removed from the scoring. A quality rating of 7 was used instead of 9 for
scoring.
CHARMS Checklist
The CHARMS checklist is designed to aid in reviewing and appraising of all types of
primary prediction modelling studies (Moons et al., 2014). Additionally, it aids in data extraction
of the individual studies in eleven domains: source of data (type of study), participants, predicted
outcomes, candidate predictors, sample size, missing data, development, performance,
evaluation, results, and interpretation/discussion. (Moons et al., 2014). Prior to this checklist
there were no systematic methods for evaluating primary prediction modeling studies (Moon et
al., 2014). Though this tool is intended for primary studies it was additionally used here to aid in
data extraction from the systematic reviews noted in this paper. The systemic reviews included
were used as guides to understand the primary model research and report the relevant themes
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within this literature review. Understanding the currently published research is an important
aspect of clarifying the gaps in research. The CHARMS checklist allowed a format to display
the relevant study data (Table 13) found in the three systematic reviews since they are lightly
discussed in this paper and highly relevant to future research or implementation of DRPMs.
Themes
It is evident in the literature that delirium results in detrimental effects for the healthcare
systems, patients, and families. The rates and healthcare costs of delirium are unchanging with
current practices in delirium risk prediction, prevention, and management and are expected to
increase as the percentage of elderly population increases. The literature uncovers a lack of
systematic methods to determine risk in current practice. The studies all report similar statistics
and report their ability to stratify risk based on statistics. Lastly, model ease of use in clinical
practice is a past barrier that must be addressed in the development of DRPMs.
The Impact on Health Systems, Patients, Families and Nursing Staff
The impact of delirium is far reaching for healthcare systems as the financial burden and
resource utilization creates a strain on our health care systems. Implementation of delirium care
pathways in acute care can decrease rates of onset, severity, and length of delirium in
hospitalized patients (Inouye et al., 1999) and reduce overall costs of hospitalization (Brown et
al., 2018). Increased length of hospitalization can lead to adverse outcomes, particularly in the
elderly due to increased frailty (Vincent, Neale, & Woloshynowych, 2001). Falls, decubitus
ulcers, feeding problems, urinary incontinence, urinary infections, and fractures are reported in
literature to be a result of extended hospitalization (Groves & Huskin, 2011). The length of stay
is a way organizational performance is measured. Preventing the onset of delirium or lessening
its effects, by the recognition of risk and implementation of preventative measures, allows
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healthcare providers to affect the length of stay and improve organizational performance
measures.
Whitehorne, Gaudine, and Meadus (2015) reported that patients post-ICU delirium had
poor or no recall of events, difficulty making connections and communicating simple needs,
struggled with distinguishing reality from hallucinations and paranoia, and recalled feelings of
being in imminent danger. Delirium creates a state of personal distress. The hallucinations are
detrimental to the long-term mental health of a patient who believes they are real while recalling
the experience (Whitehorne, et al. 2015). The following is a recollection of a recurrent
hallucination experienced by a patient who recovered from delirium. It shows that patients
experience long-term psychological trauma.
The one that was most upsetting was the monkeys … up in the lights...You could hear
them jumping up and down, and they were bawling like they were trying to get at me.
They were on all the lights, not just at the one that was at my bed but all around the
room...They were savages...I didn't know…if they wanted to get out or get at me.… I'm
still afraid to look up at the lights...And I always…whisper because I'm afraid they'll hear
me. (Whitehorne et al., 2015, p. 477)
The cognitive changes resulting from delirium may necessitate 24-hour caregivers,
causing financial strain or long-term care center placement for safety. The consequences of
cognition impairment are a loss of independence, acceleration toward dementia, and early
mortality. The effects of delirium can persist for months in 20% of the cases (MacLullich & Hall,
2011).
Caregivers offer support and provide care to family members with persistent delirium
whom are discharging from hospitals. Its noted that 80% of delirious hospitalized patients have
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family members that are their caregivers, creating a burden of care (Abrantes & Racine, 2019).
Three types of burdens laid on family members: symptom burden, emotional burden, and
situational burden (Abrantes & Racine, 2019). Symptom burden is the experience and
observation of the disorientation and personality changes that make the patient virtually
unrecognizable. Greater than 70% of spouses reported stress related to the toll of caregiving and
close family (Page & Ely, 2017). Friends and families worry that the cognitive changes are
permanent (Page & Ely, 2017). Situational burden occurs as the result of feeling loss of control,
safety concerns, lack of support, and the unpredictability of the course of delirium (Abrantes &
Racine, 2019).
Page and Ely (2017) state nursing staff caring for delirious patients experience frustration
and stress while trying to care for and comfort them (p.107). Nursing challenges occur whilst
providing basic care to ensuring safety, protecting patients from causing harm to surgical sites,
removing IV lines, Foley catheters, arterial and central venous lines; all while providing nursing
care for the presenting illness.
Current practices for Risk Determination
In the current state of delirium management, healthcare providers individually use
clinical judgment and their learned knowledge of delirium to assess a patient for delirium risk. A
clinician must recognize and be cognizant of the predisposing and precipitating factors that
trigger incident delirium. Delirium prevention bundles, clinical practice guidelines,
organizational guidelines, and hospital-specific
pathways list various risk factors, however, do not recommend specific stratification tools.
In ICU’s across the United States, standard practice is to implement the ‘ABCDEF
bundle’ to prevent delirium in the ICU, per the recommendation of the Society of Critical Care
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Medicine (2018). This “bundle” provides nurses with interventions to reduce delirium, provide
adequate pain management, and reduce the long-term consequences of delirium in adult
intensive care unit (ICU) patients (Society for Critical Care Medicine [SCCM], 2018). This
bundle called the Assess, prevent, and manage pain; Both spontaneous awakening and breathing
trials; Choice of analgesia and Sedation; Delirium assess, prevent, and manage; Early mobility
and exercise; Family engagement /empowerment, is implemented for every ICU patient, since all
ICU patients are considered at high risk for delirium and poor clinical outcomes. A recent study
by Pun et al. (2019) found that over 15,000 patients receiving the ABCDEF bundle interventions
had decreased rates of incident delirium, restraint use, intubation length, mortality rate,
readmission to ICU, and were more likely to discharge to home rather than long-term care
centers. This study also noted a decrease in the length of mechanical ventilation, coma, and
delirium (Pun et al., 2019). Due to the positive effects of the ABCDEF bundle, the SCCM
recommends all ICU’s to employ this delirium bundle as the rates of delirium can be diminished
and healthcare quality can be improved (SCCM, 2018).
Bundles of care for the inpatient units are less frequently employed; thus, patients
continue to develop delirium at uncontrolled rates on medical units. The Hospital Elder Life
Program is a research-based comprehensive program for the prevention of delirium in
hospitalized older adults (HELP, 2019). This program utilizes hundreds of volunteers to assist
with activities to keep patients alert and awake during daytime hours, meet hydration and
nutrition needs (feedings), and encourage movement. According to their website, there are 200
sites (in 32 states and 11 countries) that have employed this program, including Methodist
Hospital in Minnesota (HELP, 2019). The study by Zaubler et al. (2013) showed that
implementation of the HELP program resulted in a 40% relative reduction in episodes of
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delirium, a two day decrease in the length of stay, and a nine-month cost-savings of $841,000.00
(Zaubler et al., 2013). Additionally, the HELP website also notes that HELP implementation
studies have resulted in the prevention of cognitive decline, reduced nursing home placement,
decreased hospital rates of falls, and a reduction in the use of 1:1 sitters (HELP, 2019).
Brown et al. (2018) published an impact and implementation study on the AWOL tool in
practice as part of a multicomponent prevention pathway (AWOL, CAM, and interventions to
those triaged as a score of ≥ 2). This study reported a decrease in length of stay of >2 days,
decreased 30 day re-admission rates from 11% to 5.45%, less restraint and 1:1 sitter use (Brown
et al., 2018). There were no reductions in hospital days which were explained by stating that the
interventions employed were studied in general medicine populations, but the impact study had a
majority of neurological patients and increased recognition and sensitivity to delirium in general
may elevate diagnosis of delirium.
Supporting Evidence for Risk Stratification
Delirium risk determination and prevention strategies are recommended by organizations
such as NICE Delirium Guideline, the Iatrogenic Delirium Change Package, Delirium:
Guidelines for General Hospitals, and the Delirium Prevention Strategies by the ANA (2016).
Each of these documents list the risk factors but not one of the guidelines describe a method to
adopt for a consistent, system-wide assessment for risk stratification. Clinical practice guidelines
were reviewed in an attempt to clarify current practice to determine risk and not to review them
for the purpose of interventions and application to practice, thus they are not critically appraised
in this literature review.
The iatrogenic delirium change package was the only guideline to state the following
ideas for practice change:
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Adapt and adopt a risk assessment tool that examines the following risk factors:
age, dementia, metabolic imbalance, hypertension, alcohol abuse, severity of
illness, coma and benzodiazepine administration.
Assess the risk for delirium upon hospital admission, transfer within hospital or
change in patient behavior.
Develop prompts to promote the completion of the assessment and include the
assessment on the admission checklist or in charge nurse rounds (HRET, 2018, p.
6).
The American Nurses Association (2016) developed a delirium prevention pathway that
again states that the recognition of risk is the first step. The pneumonic, MIND SPACES, was
created to aid healthcare providers to recall the predisposing and precipitating factors. Since this
technique has not been researched or reported in quality improvement studies, it is difficult to
determine its effectiveness and assumes staff will recall this acronym. As with previous
guidelines, the ANA did not create this to be a DRPM, but simply a list of risk factors (ANA,
2016). Of note, NICE Guidelines state that all adults whom are at risk for delirium and are
newly admitted to a hospital or long-term care center should receive a range of tailored
interventions to prevent delirium (NICE, 2010).
As evidenced by the steady rates of delirium, the current methods of determining risk for
delirium are failing the at-risk population. Healthcare providers fail to recognize both the risk of
delirium and the onset of delirium all together; thus, clinical judgment alone is not enough to
change the trajectory and prevent delirium from occurring. Implementing DRPM’s into practice
may improve recognition of delirium and diagnosis rates of delirium, as well as prevent its onset
by providing time for interventions to be applied, thus preventing modifiable triggering events
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from occurring (Douglas et al., 2013). Implementation of preventative interventions in practice
are recommended by the SCCM, ANA (2016), and clinical practice guidelines. Within the next
sections, the reader will be introduced to the statistics of risk prediction models to obtain a
baseline understanding of the accuracy of the DRPMs presented in this review.
Delirium Risk Prediction Models: The Statistics
In the following paragraphs studies are compared based on their ability to accurately
predict and stratify the risk of developing incident delirium. Each study followed a similar path
for determining the independent predictive factors. They collected baseline characteristics such
as demographics, living situation, age, sex, comorbidities, cognitive status, and varied in their
collection of baseline lab values, medications, vital signs, infection, fracture, and admitting
diagnosis. One study included dependency with activities of daily living, presence of urinary
catheters, IV therapy, oxygen, and pressure sores as characteristics (Martinez et al., 2012).
A total of seven models were selected for appraisal and comparison for this literature
review. They are:
‘Clinical Prediction Rule for Delirium’ by Martinez et al. (2012);
Chi-Square Automatic Interaction Detector (CHAID) decision tree model by
Kobayashi et al. (2013);
‘AWOL’ by Douglas et al. (2013)
Delirium Prediction Score (DPS) by Carrasco et al. (2014);
‘E-NICE’ by Rudolph et al. (2016)
‘Delirium Susceptibility Score (DSS)’ by Pendlebury et al., (2016a);
Automated machine learning tools (Gradient Boosting Machine (GBM) by Wong et
al., (2018).
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An additional study updating four of the models in preparation for a new model (DSS)
was included in the review:
Delirium risk stratification in consecutive unselected admissions to acute
medicine: validation of externally derived risk scores (Pendlebury et al. (2016a)
An implementation study completed by Brown et al. offers significant clinical support of
DRPM implementation into practice:
Predicting inpatient delirium: The AWOL delirium risk-stratification score in
clinical practice (Brown et al., 2017)
Another study included shows evidence in favor of DRPMs in practice is an implementation
and clinical impact study:
Evaluation of a multicomponent pathway to address inpatient delirium on a
neurosciences ward (Brown et al., 2018)
For statistical comparison, all seven prediction model studies and the additional three
supporting studies reported the area under the curve (AUC) statistics as either the area under the
receiver operating curve (AUROC), AUC, receiver operating curve (ROC), or the concordance
statistic (c-statistic or c-Index), thus enabling ease of comparison of discrimination. A model's
ability to differentiate between those at high risk and those at low risk is its ability to
discriminate. Attention should focus on the sensitivity (true positive rate) more than the
specificity (true negative rate) when choosing tools to predict delirium risk, allowing for
stratification by including nearly all that developed delirium (Ho, et al., 2019). The calibration
of a model determines if the observed risk matches the predicted risk. Thus, both calibration and
discrimination are essential to prediction modeling. Calibration is often not reported in
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prediction models; in these models, calibration results as percentages of positive delirium
patients per risk level (Table 14).
The models included in this review are those with moderate to good performance range
like the AWOL risk score developed by Douglas et al. (2013), which reported an AUC of 0.69 in
the development study, an AUC of 0.73 in the Pendlebury et al. (2016a) update study, and a
AUC 0.69 in the comparison study by Brown et al. (2017). Wong et al. (2018) compared the
AWOL to newly developed electronic DRPM’s. The AWOL models’ discrimination in the
external validation cohort resulted in an AUC of 0.678 (showing consistency of the model from
the original development by Douglas et al., 2013). The logistic regression model developed in
the Kobayashi et al. 2013 study, was among the best performing of the non-electronic group with
an AUC of 0.79 in the validation cohort. Interestingly, the validation cohort performed slightly
better than the development cohort that had an AUC of 0.78, which can suggest over-fitting of
the model. Over-fitting of the model to the sample population is possible when the AUC in a
validation study is higher than that in the development cohort and means that the model was
fitted to the validation population and thus may not be generalizable to other populations without
further external validation studies to prove otherwise.
The future of risk prediction lies in machine learning or neural networking. The advent
of the electronic medical record presents an interesting possibility for future prediction modeling
as they record relevant patient information. These predictors are weighted (weights are
commonly derived by logistic regression), which results in a score, then these scores are fitted
into the models’ predetermined levels. These models rely on accurate chart documentation,
including complete and accurate history, diagnostic coding, and results of labs. The electronic
versions included in this study are by Kobayashi et al. (2013) (CHAID decision-tree model),
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Rudolph et al. (2011) (e-NICE), and the Wong et al. (2018) (machine learning models; “gradient
boosting machine (GBM)”, “Penalized logistic regression (PLR)” and “random forest” analysis
(RF)). The CHAID had the lowest AUC in the validation cohort at 0.82. Wong’s RF model had
an AUC of 0.848, the PLR model is 0.854, and the GBM had an AUC at 0.855. The e-NICE
model was the highest with an AUC of 0.91 (Brown et al., 2017).
The non-electronic high performer was Martinez et al. (2012), as the validation cohort
had an AUC of 0.85, keeping in mind that the development cohorts AUC was 0.77 (considering
overfitting of the model). The authors noted that that additional work to rule out overfitting is not
needed as it was of no clinical significance. The validation study had the same patient
population and setting with a higher incidence in delirium diagnosis (25% vs. 13%) in the
development cohort and more dependence on others for assistance with ADL’s. A second nonelectronic model with high discrimination was found in the external validation study that
Pendlebury et al. (2016a) completed, the model created by Isfandiaty found an AUC of 0.83.
(validation of this developed tool was not completed; therefore, it is not included in the literature
review). Statistical comparisons of the seven studies, along with the model update study by
Pendlebury et al. (2016a) are entered into a table 14.
The capacity to stratify risk. The ability of a model to stratify risk is evaluated based on
the accuracy of the proportion of each population’s allocation into risk levels (Steyerberg, et al.
2010). The best models will effectively place subjects at both extremes of the risk distribution,
thus enabling clear implications for future actions. Perfect models assign into only the highest
risk and the lowest risk levels with no in-between, leaving no room for error of missing an event.
Cook notes that there are no perfectly calibrated models (2008). A useless model will assign the
same risk to the entire population, similar to the flip of a coin, which is equivalent to an AUC of
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0.50 (Steyerburg et al., 2010). A model’s calibration, or capacity to stratify the population into
risk categories, and the accuracy of the classifications are the critical attributes of a model.
For comparative purposes, healthcare providers can review the true positives and
negatives, false positives and negatives, as well as percentages of definite diagnosis, and ensure
that the rates of delirium are increasing with the higher risk categories. Martinez et al. (2012),
Douglas et al. (2013), Kobayashi et al. (2013), and Rudolph et al. (2016) models compare each
risk level based on percentages of those with and without delirium in each level. Martinez et al.
(2012) has the highest percentage of patients at their highest level; 64% of those with delirium
are included in this level. Of note 44.4% of those with a score of ≥1 (highest stratification score)
developed delirium, and only 7% of those classified as low risk developed delirium. The
Martinez et al. model also has the potential to limit necessary interventions to 53% of the total
population, making rationing of interventions possible, which is the goal of stratification of risk.
The Douglas et al., (2013), AWOL score sets a score of ≥ 2 as high risks. Eleven
patients in this cohort are positive for delirium or 13.5% of the 165 patients included, of
importance is that only 3.5% of all those said to be low risk developed delirium showing good
calibration. The score of ≥2 captured 11 positives out of fourteen, which results in 79%
accurately stratified. At this score, interventions would be limited to only 49% of the population
allowing for an improved resource utilization. Interestingly, at zero factors one still developed
delirium and a score of four, none developed delirium. The sample size of this study was just
165 patients, which could account for less reliable results. The Pendlebury et al. study (2016a)
updated the AWOL model and improved the capacity to stratify risk as evidenced by an
improved AUC of 0.78 and the Se still increases with each risk level and PPV increasing to 0.70
for three factors.
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Comparatively, the CHAID decision-tree model, is unique in its application and
statistical reasoning (Kobyashi, 2013). It can be used both electronically and on paper as an
algorithm as demonstrated in Table 4. There is no cutoff score for risk stratification; instead, it
is a model that identifies the presence of risk factors and follows a decision-tree to determine risk
levels. Those noted to be moderate to highest risk levels are of two categories. The first split is
those with a known history of delirium. The study notes that those over age 75 have an
increased risk and account for 7.9% of the incidence of delirium. This decision-tree does not give
the compounding risk of a patient whose age is ≥ 75 with malignancy and impaired ADL’s thus,
the reader presumes very high risk.
In the Rudolph et al. (2016) validation study (e-NICE), the rates of incident delirium
increase significantly with increasing risk scores. With the addition of the Modified Richmond
Agitation Sedation Scale (mRASS), there is an increased ability to stratify the high-risk category.
In this model, risk levels that were high and very high-risk combine capturing 27 positive
patients out of 246 total patients, but misses 16 of those delirious or 6.5%, which is unacceptably
elevated since the goal is to prevent the highest number of those who developed incident
delirium. The e-NICE model performs better in the developmental retrospective cohort than the
prospective cohort as the development cohort has lower percentages of missed delirium in those
categorized ≤5. For scores ≥6, the true positive rate (TPR) is 63% (27/43), and the false positive
rate (FPR) is 33% (60/182), showing that more patients were correctly classified as a high risk
rather than falsely classified. Eighty-seven patients were high risk out of 246, therefore only
35% (81 patients) of the total population would require interventional pathways.
The researchers in the consolidated e-NICE, Rudolph et al. (2016) model, offered
additional mental status assessments for possible addition, such as the mRASS. Inclusion of the
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mRASS would increase the number to treat to 108 with 40.7% of them delirium positive. If the
score decreased to ≥3, it would capture 33 more positively delirious patients and increasing
treatment to 52.4% of the total population, still allowing for triaging, thus the allocation of
resources.
The Pendlebury et al. (2016a), Pendlebury et al. (2016b) and Carrasco et al. (2014)
studies display the Se, Sp, PPV, and NPV of each level of prediction. In the Pendlebury (2016a)
study, the models compared and updated were Inouye et al., 1999, Martinez et al., 2012, Rudolph
et al., 2011, and Douglas et al., 2013. The updated tools contained very similar predictors while
their Se, Sp, PPV, and NPV also resulted similarly. This study reported that no model
statistically performs significantly better than another. As a result of this update study,
researchers developed a Delirium Screening Scale (DSS) model which improved on the Se, Sp,
PPV, and NPV as evidenced by an AUC of 0.81 (Pendlebury et al., 2016b). This is one of the
few studies that reports odds ratio which for a score of 5-7 vs a score of ≤2 is 25 with a relative
risk of 13 proving that the higher score is related to greater risk. The odds ratios for all the
scores for this model and other models are noted in Table 14.
The Carrasco et al. (2014) study is unique with the use of a mathematical equation
formulated out of lab values (BUN/Creatinine ratio) and the Barthel Index. Any score > -240
predicts high risk, and interestingly, 99% of those that are low risk (<-240) did not develop
delirium. This tool was exceptional at stratifying those at high risk for delirium; however, the
Barthel Index adds complexity to an assessment, and it may have less merit clinically.
The Wong et al. (2018) study is unique as it compares and externally validates the
AWOL tool while it integrates hundreds of predictors (796 variables and the GBM contains 345
variables) into three machine e-learning models resulting in very high predictive values and
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AUCs. All of their models use chart abstraction methods to calculate and stratify the risk score.
The strength of this model is the ability to adjust the sensitivity and specificity to the desired
level of the individual facilities. The statistical power this tool has allows for improved
accuracy, which results in a narrowed number of patients targeted for interventions as evidenced
by the number needed to screen of 4.8.
The DRPM’s must have the ability to stratify risk levels appropriately, allowing for
allocation of the preventative interventions for a targeted population. Outcomes of clinical
application studies, such as Browns’ (2017), are among the best clinical evidence to support or
negate the use of a model in clinical practice (Brown et al., 2017). The statistics are represented
in Table 14 which report the values as they relate to the predictive power of each stratified risk
level, from which critical appraising and evaluations for clinical application can consider all
scenarios.
Model Feasibility in Practice
To understand model feasibility in practice it is necessary to investigate the barriers to
adopting DRPMs in current practice. Three studies were discovered that reported the barriers to
clinical practice through the perception of a physician or a nurse. The Newman et al (2015) and
Kappen et al. (2016) studies reported on physician perceptions and the Brown et al. (2015) study
reported on the nurses perceptions. The systematic review by Newman et al. (2015) reported the
barriers to clinical implementation of DRPMs. One obstacle is that health care healthcare
providers perceive their use as complicated and time-consuming (Newman et al., 2015). Some
of the variables included in the models were not available or tested upon admission (Newman et
al., 2015). The overall theme in this review of studies was that the complexity of the predictors
limited the use of prediction models.
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Since the study by Newman et al. (2015), there was a study reporting the implementation
and impact of a DRPM on a medical ward as part of a nurse-driven delirium care pathway by
Brown et al. (2015). Nurses are responsible for completing the AWOL tool; unfortunately, the
reported completion rate was only 48.6%. The researchers, Brown et al., then followed up with
nursing in regard to what were the barriers to completion. The obstacles published are: (a) Lack
of nurses time to complete (b) perceived lack of training, (c) the documentation was not required,
(d) nurses were frequently disrupted in their workflow, and (e) nurses stated that it wasn't a unit
priority (2017). The research team addressed all barriers and found an improved completion rate
of 90%; thus, they suggest investing in more resources before and during implementation,
supporting the use of the model (Brown et al., 2015). Additionally, Brown et al. found that the
AWOL score could not be completed in patients who had a language barrier (somnolence,
aphasia, or a non-English primary foreign language). They note modifications of this tool
include translation and alternative assessments for cognition in aphasic patients similar to those
used in intubated patients (Brown et al., 2017).
Kappen et al. (2016) studied physician perceived barriers to implementing a risk
prediction model on postoperative nausea and vomiting. They noted that physicians state the
outcome is not the main area of attention, their decision-making process is intuitive rather than
analytical, knowledge of the risk level should be accompanied by corresponding management
recommendations (knowledge of risk itself is insufficient), and prediction models do not weight
benefits and harm of the interventions (Kappen et al., 2016).
To combat these barriers actionable interventions based on risk need to accompany the
risk model, risk stratification should be automated into the workflow, reasoning explained with
evidence to back them including how the risk is determined, and relevance to the physicians
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direct practice will result in improved perception (Kappen et al., 2016). Knowledge of the
barriers to use of risk prediction models will aid in creation of structured implementation of them
in practice.
There are two DRPMs currently utilized in practice, the AWOL model and e-NICE
(Rudolph et al., 2016; Douglas et al., 2013). Bedside RNs complete the AWOL upon patient
admission and the e-NICE is a completely automated tool alerting healthcare providers to the
risk level. The e-NICE electronic abstraction tool provides the Veterans Administration (VA)
hospital system healthcare providers with a daily list of those inpatients at the highest risk. Of
note, the AWOL study is researched in three additional reviews: Brown et al., 2017; Pendlebury
et al., 2016a; and Wong et al., 2018. The Brown et al. (2017) study they found the AWOL has
AUC of 0.73 with 4% of the delirious with a score of 0, 6% with a score of 1, 42% with a score
of 2, and 57% with a score of 3, and none of the incident delirious patients in this cohort had a
score of 4. In the Brown et al. (2017) study, they had an AUC of 0.73, the Pendlebury et al.
(2016a) study resulted in an AUC of 0.78, and the Wong et al. (2018) found an AUC 0.678.
The AWOL tool is available on the software application MdCalc (2017), improving its ease of
use and availability.
Barriers created by DRPMs prevent the implementation of these systematic methods to
predict risk in clinical practice. The more recent DRPMs researchers have answered this with
risk prediction models that include predictors that are available upon admission. Models that
include complex assessments such as the Barthel index or a mRASS are being rejected by
healthcare providers because they are too time consuming. Automated risk scores may be the
answer to the feasibility concerns as they allow a hands off assessment of risk, with predictors
drawn from the electronic medical record. The models that are automated are the Wong et al.,
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2018 and Rudolph et al., 2016. Unfortunately, some healthcare systems are not ready for
automation. The AWOL (Douglas et al., 2013) contains predictors to be assessed upon
admission and an online calculator for scoring on MdCalc. The DSS model (Pendlebury et al.,
2016b) contains predictors that are readily available upon admission.
The ideal time to assess for delirium risk is upon admission before delirium develops, and
at a point that preventative interventions implemented are effective (Douglas et al., 2013; Wong
et al., 2018). Thus, the ideal model contains predictors commonly obtained on admission or
readily available in the chart. The following studies by Douglas et al. (2013); Martinez et al.
(2012); Pendlebury et al. (2016b); Rudolph et al. (2016) & Wong et al. (2018) included
predictors that were available upon admission or shortly thereafter, increasing their clinical
merit.
The first DRPM included four predictors: the Acute Physiology and Chronic Health
Evaluation II score (APACHE II), history of cognitive impairment, presence of dehydration
(BUN/Creatinine), and visual impairment (glasses or blindness) (Inouye et al., 1993). The
APACHE II score created complexity by requiring assessments including the Glasgow coma
scale score (GCS), temperature, Mean Arterial Pressure (MAP), heart rate, respiratory rate,
FIO2, and the lab values of a PaO2, arterial pH, bicarbonate, sodium, potassium, creatinine, and
hematocrit (Knaus et al., 1985). Not all of these tests (arterial blood gas to assess the PaO2, pH,
and bicarbonate levels) or assessments (Glasgow coma scale) are clinically necessary for
evaluation of all patients admitted resulting in ordering additional tests to complete the risk
model. Extra testing increases healthcare costs, pain, and exposure to the risk of procedures such
as the arterial blood gas (ABGs) collection. This model is not adopted in clinical practice due to
the complexity of obtaining all the added clinical information necessary for the scoring to occur
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(Douglas et al., 2013; Pendlebury et al., 2016a). Refer to Tables 1-7 for a simplified way to
discover the predictors included in each of the seven models.
As evidenced by Inouye and colleagues' model of 1993, DRPM must contain predictors
that are likely to be obtained upon admission (laboratory studies or assessments), carry a low
burden to collect, and quickly calculate the risk levels. As Rudolph et al. (2011), Pendlebury et
al. (2016a), and Wong et al. (2018) point out, tools for future practice need to be simple,
credible, and externally validated. Additional specialized assessments such as the MoCA
(Montreal Cognitive Assessment), MMSE (Mini-Mental Status Exam), APACHE II Score
(Acute Physiology And Chronic Health Evaluation), Barthel Index, or the Charlson Comorbidity
Index are too cumbersome to include in a bedside risk prediction model (Newman et al., 2015).
These assessments require additional training for staff and are of less clinical use due to low
completion rates (Carrasco et al., 2014). In the updated Pendlebury (2016a) study,
modifications to the models for ease of use without impacting the accuracy of prediction.
Perhaps the most straightforward yet technically complex score is the machine learning
models in the study of the Wong et al. (2018). All tools reported in this study have published
superior statistics in comparison to the non-machine learning tools. This study resulted in the
Gradient Boosting Machine (GBM) model, which contains 345 predictors electronically
collected from the chart allowing for the automated extraction of the health data and alerting the
clinical teams to elevated risk scores. The authors compared the model to the AWOL and noted
that the GBM could target those at the highest risk with improved accuracy, thus limiting
focused interventions to less than half that of the AWOL (Wong et al., 2018).
The Wong et al. (2018) electronic models are very complex computerized programs and
require technical builds for integration into digital charting systems. It provides real-time
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calculations of risk without additional assessments by healthcare providers (Wong et al., 2018).
In the current healthcare environment, it is desirable because it frees up healthcare providers
time.
Summary of Research Findings
The statistical evidence confirms validated delirium risk prediction models have the
ability to stratify the risk for delirium. Each of the models report both discrimination and
calibration as the AUC, sensitivity and specificity, or percentages of positive outcomes in
relation to risk scores. A model that can discriminate has the ability to categorize high versus
low risk. A well calibrated model effectively determines higher risk levels in correlation with
increasing true positive rates. However, a model cannot be implemented simply based on its
statistics. Models for clinical practice must also be feasible in practice (easy to use, consume
very little clinical time to preform), utilized at the appropriate time, and must stratify the risk
accurately (minimal false negative cases).
The systematic review by Newman et al. (2015) studied the barriers to implementation
were that healthcare providers perceived too much time to assess and score models, models are
complex and not understood, limited supporting evidence of the models clinical impact, and
there were not recommendations for clinical decision-making based on the level or risk.
Interestingly the automated computerized models (e-NICE and GBM) report both the highest
ability to stratify risk with both a high Se and Sp, limiting the interventions to a narrow group of
patients with minimal miss classification of positive cases of delirium. Because these model
results are computer generated, they require no further assessments for providers, making them a
very attractive option.
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As for as implementation and impact studies, Newman et al. (2015) was unable to
discover any published studies and noted they did not find evidence that any models were
employed in practice prior to the studies publication. New evidence has emerged reporting
successful implementation of a delirium prevention care pathway using the AWOL model to
triage the use of interventions to those assigned a risk score of ≥ 2 (Brown et al., 2015; Brown et
al., 2017). This evidence shows that use of a DRPM, as part of a delirium prevention bundle,
can diminish the severity of delirium mitigating some secondary effects. It also relays a benefit
of decrease in length of stay of > 2 days (Brown et al., 2017). The Brown et al. (2017) study is
the only impact study discovered during the literature search employing the use of a DRPM as
part of a multicomponent interventional pathway. This evidence suggests that DRPMs should
not be implemented alone, but within a care pathway to impact the consequences of delirium.
DRPMs allow resources to be allocated to those at greatest risk, decreasing use of limited
resources such as volunteers, physical and occupational therapy, psychology consults, pharmacy
consults, or involvement of a geriatrician. The preventative strategies implemented must
proceed the triggering factor of modifiable precipitating factors to be effective (Brown et al.,
2017).
What methods are recommended for clinicians to triage preventative interventions for
those at highest risk for development of delirium? Clinical practice guidelines and associations
such as the ANA, SCCM, and HRET support determination of risk as the first step to
multicomponent prevention pathways. Each of these organizations or guidelines discuss the risk
factors for delirium and provide a long list or a pneumonic of them to be recalled during clinical
practice. The ANA and SCCM do not discuss DRPM or suggest any systematic methods for
determining risk. The HRET (2018), however, discusses risk and recommends employing a
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delirium risk prediction model. Interestingly this published “package of change” is the most
recently published recommendations for iatrogenic delirium management.
Gaps in Literature
Clinical decision-making is aided by risk prediction models in many settings of medical
care. There are no studies reporting or focusing on what effects DRPMs have on the clinical
decision-making of clinicians. The recommended delirium preventative care pathways, unlike
risk stratification for stroke (CHA₂DS₂-VASc, which directs clinicians on use of anti-coagulation
therapy based on calculated risk score (January et al., 2014), do not provide stepped levels of
interventions based on calculated scores. Studies additionally stated that determining patients at
risk and alerting providers to the elevated risk may improve recognition and diagnosis of
delirium risk (Douglas et al., 2013; Rudolph et al., 2016). There is no clear evidence to support
the claim that DRPMs enhance diagnosis of delirium by clinicians. Reporting evidence to
address these gaps may improve support of DRPMs use in clinical practice.
Some models being developed are aimed at a very narrow population of focus, such as
models for ICU, surgical patients, or patients with fractures rather than a broader, generalized
population like the general acute care hospital admission population (Lindroth et al., 2018).
Lindroth et al. (2018), with a focus on older, found 23 prediction models, 11 medical, 3
medical/surgical, and 9 for various surgical procedures. Another study reported finding 37
DRPMs, 16 focused on cardiovascular surgery, six on orthopedic surgery, and the other 15 from
various hospital unit settings (van Meenen, L., van Meenen, D., Rooij, & Riet, 2014).
Interventions suggested by guidelines for management of delirium were created based on
general medical care patient data sets (Brown et al., 2017), thus it is a mixed message that risk
prediction is not generalized, but the prevention is generalized. The effectiveness of
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interventions in other settings such as ICU or post CV surgery have not been studied, leaving an
additional gap in the literature.
Clinical practice guidelines and organizations such as the American Nursing Association
(2016) note that assessment of risk is the first step to preventing delirium, yet not one
recommends a delirium risk prediction model. It may be attributed to the fact that there only two
published implementation studies (Brown et al., 2015; Brown et al., 2017) and one impact study
(Brown et al., 2017). Impact and implementation studies report on the findings during
implementation and show what impact it has on the population. Significant gaps in literature are
few studies have been externally validated, more models exist than validation studies, and it is
rare to find reporting of impact studies or clinical improvement projects with the use of DRPM.
It is possible that support for implementation of DRPMs in practice would increase if all the gaps
in literature were studied and published.
Conceptual Framework: Stetler Model of Research Utilization
The Stetler Model of research utilization is the guiding framework for this literature
review. It directs practitioners to develop common standards, tools, and policies that are
supported by evidence-based research. It guides clinicians in critically reviewing and reflecting
on practice to understand the relationship between research use and evidence-based practice.
This model sets criteria and sets standards to view a problem (Stetler, 2001).
The five phases start with the literature search that guides the structure of evidence
reported within this review. The subsequent sections are outlined based on these three phases
from the Stetler model (2001). Phases four and five of the model relate to implementation,
which is not the purpose of this literature review thus were not used for this project. Figure 1
was created by this author to show the three phases used in this paper using a circular figure.
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Phase one begins with preparations including defining the purpose of the research, the
context of the studies, and levels of evidence (Gray, Grove & Burns, 2017). Phase two is the
validation phase which analyzes of the overall credibility, applicability, and operational details of
the studies and aids in the evaluation of the fit of each research study to the purpose of the
inquisition. Phase three is the comparative evaluation or decision-making phase, the evaluator
organizes and displays the research findings based on their similarities and differences. Each
phase builds on the findings from the previous phase adding depth of understanding of the
studies. Phase three ends with recommendations for practice based on the evidence presented.

PHASE 1

PHASE 2

•PREPARATION
•Id the purpose, note the reasons
for model creation

•VALIDATION
•Assess the sources of evidence, reflect on the
meaning of each source, note relationships

PHASE 3

•COMPARITIVE EVALUATION/
•DECISION MAKING
•Synthesis of evidence for final conclusions
and recommendations for practice.

Figure 1. The Stetler Model of Evidence-based Practice figure for phases one through three
(2001).

Phase One
Preparation for this integrated literature review consisted of identifying the purpose,
context, and sources of evidence to include in this literature review/comparison study (Gray,
Grove & Sutherland, 2017). During this phase the criteria was developed for inclusion: level of
evidence a model contains, the research method (retrospective or prospective cohorts), the
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inclusion of developed non-validated studies vs. validated studies, and the population of focus
for the DRPMs. This led to the purpose of this review and the guiding questions.
Phase Two
In phase two, the overall credibility, applicability, and operational details were assessed.
Each study was evaluated for the level of evidence and quality of reporting of the study with the
use of the CHARMs checklist and the Newcastle-Ottawa scale. During this phase reflection of
the meaning of each study was done as this author reviewed the variables included in the
prediction model and its ability to perform its intended purpose. For ease of comparison
literature tables were created (Table 12).
Phase Three: Review of Studies
In phase three a comparative evaluation between the selected studies was completed.
This comparison guided the final recommendations for practice based on the evidence presented
by the authors of each DRPM. A table of statistical comparison and the tables outlining the
factors in each DRPM were created during this phase (Table 14 and Tables 1-7 respectively).
Each phase of the Stetler Model builds upon the previous stages, the figure was developed to
show this relationship and the ability to step from level 1 to level 2 or back up to level 1 again as
the direction of the literature changes with discovery or new evidence.
Conclusions
The risks of complications are high for our fragile elderly patients being admitted into
hospitals. Reactionary clinical practices are no longer valid in the prevention and treatment of
delirium. The costs associated with delirium are not limited only to financial losses, as delirium
affects the quality and quantity of a person’s life. Cost and quality of care are leading healthcare
clinicians to look for innovative ways to deal with challenges such as delirium. The goal of
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medical care is changing from treatment of conditions to prevention. Today, clinical decision
making for delirium prevention is not aided by DRPMs. This gap in preventative care exists
because past models were not feasible to complete in clinical practice. More attention is needed
to employ more recently developed models and develop preventative protocols for delirium
across all acute care hospital settings.
The seven models included in this review have statistically proven their ability to stratify
risk. What they have not proven is clinical effectiveness of DRPMs in practice. The recently
published impact and implementation studies show promise in both the use of DRPM in general
and their use within a delirium prevention care pathway (Brown et al., 2016; Brown et al., 2017).
DRPM are suggested for use as a clinical decision tool to triage implementation of delirium
prevention pathway or bundles of care (Douglas et al., 2013).
Clinical guidelines recommend assessing risk factors however they do not offer
systematic methods to determine the risk of developing delirium. The DRPM’s presented in this
literature review are evidence that stratifying the risk of delirium is possible using validated
models. The ability to stratify risk is the key to triaging resources to implement preventive
interventions that are resource-intensive and expensive. Stratifying risk and applying
interventions to those at greatest need has been shown to be cost-effective in implementation
studies (Brown et al., 2017).
The conclusions drawn from the appraisal and synthesis of the models and supporting
literature guide the recommendations for practice. The conclusions are:
The literature shows evidence that DRPMs could be used in clinical practice as part of a
multi-component interventional pathway
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Without further published impact studies or quality improvement studies that use DRPMs
for triaging of interventions the guidelines cannot recommend a tool for use
Delirium is a serious medical and psychiatric problem, leading to adverse health events,
for which preventative measures are stated to reduce the rates, given the 2050 projected
increase in elderly adults, the time to prevent is now
Interventions for delirium should be studied in the population for which the DRPM is
aimed
There are no known risks of the preventative interventions, thus it is assumed that
implementing preventative pathways can only provide benefit
Healthcare needs standardization of the processes of preventing, managing, and treating
delirium
Adding actionable recommendations to a care pathway may provide clinicians with a
reason to implement interventions and promote acceptance of a model by staff
While complex to implement, automated models provide consistency and liberates time
normally is spent by practitioners calculating a risk score
Recommendations
Implementing standardized healthcare processes are best accomplished by the
development of care pathways or care bundles. According to the Institute for Healthcare
Improvement a bundle is, "a structured way of improving the processes of care and patient
outcomes: a small, straightforward set of evidence-based practices....that, when performed
collectively and reliably, have been proven to improve patient outcomes." (Evidence Based Care
Bundles, para. 1).
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A recommended delirium preventative pathway will include three main elements; (a) an
evidenced based delirium screening/diagnostic tool with high accuracy rates, such as the
Confusion Assessment Method (CAM), (b) an automated DRPM, (c) evidence-based delirium
prevention interventions as recommended by the NICE guideline (NICE, 2010) (or a similar
guideline) with the addition of stepped interventions that increase in intensity of resource
utilization as the level of delirium risk increases. During a personal communication with Dr.
Douglas, a neurohospitalist from the University of California San Francisco hospital, he stated
that two mistakes his team made when implementing the AWOL into practice was not using the
CAM as a diagnostic tool and not spacing the implementation of the NuDESC for delirium
screen adequately before implementation of the AWOL into practice. He suggested that prior to
any implementation of a DRPM or preventative care pathway, a delirium screening tool such as
the confusion assessment method (CAM) be employed for a minimum of three months (V.
Douglas, personal communication, May 17, 2018). Adoption of an accurate diagnostic tool as a
first step will allow for gathering of clinical data on current delirium rates.
Educating all staff before the implementation process on the evidence and predictive
ability of the model may improve the perceived value, increase acceptance, and improve belief in
the care pathway (Kappen et al., 2018). Education is priority prior to implementation of any of
the five elements of a delirium prevention care pathway. Additional Education on the
epidemiology, pathophysiology, diagnosed criteria, risk factors, methods to screen for onset, and
evidence-based interventions for prevention of delirium need to be provided to staff.
Recommendation for a Specific DRPM
Automated risk scoring allows for provider notifications of risk levels without increasing
their workload; therefore, the use of automated models is recommended as a way to break the
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barrier to implementation. The GBM (Wong et al., 2018) or the e-Nice (Rudolph et al., 2016)
are the recommended models, they are automated scores and have the highest Se and Sp of any
tool. Of note the e-NICE is currently implemented without a care pathway at 118 VA hospitals
(J. Rudolph, personal communication, June 14th, 2018).
Recommendations for Research
Decisions to implement evidence-based clinical practices would ideally be supported by a
large multicenter pragmatic randomized control trial (RCT). A study of this level assesses the
strengths of the model, limitations, and its effectiveness as a clinical decision-making tool.
However, RCTs are difficult to conduct on the effectiveness of care pathways because of
operational and ethical considerations such as the withholding of effective evidenced-based
interventions from the control population (Cheah, 2000). The impact of a DRPM cannot be
studied independent of prevention strategies because the prediction models use is only to detect
if there is a risk of delirium and does not provide interventions to effect patient outcome.
Quality improvement (QI) projects are an integral part of good clinical practice and are
designed to implement existing evidence-based knowledge to bring about improvements at the
local level (Kappen et al., 2018). The AWOL impact study by Brown et al., (2018) is evidence
that reporting of QI projects produce subject matter knowledge. The recommendation for future
practice is that hospitals execute a QI project with the intent to decrease delirium rates and to
decrease the negative effects on healthcare systems, patients, and families by mitigating the
severity of delirium. The QI project would be a unit based project with the implementation of a
delirium screening tool, a delirium risk assessment model, and evidence-based interventions.
The study results ideally would be published to allow other healthcare teams to learn from the
experiences and learn of the impact that the interventions in the QI produce.
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The Stetler Model of Evidence Based Practice was practically employed with the vision
that this literature review is a launching point to implementation. Progressing this evidence into
the fourth and fifth phases of the model could be done as doctoral student or healthcare provider
to implement a delirium care pathway into clinical practice. The last two phases of the Stetler
Model can guide putting research into clinical practice. Future doctoral students should note that
the Wong et al., (2018) computer model can be requested for the goal of clinical application.
Implications for Nursing
The Institute of Medicine's report in 2000 states that it is the responsibility of every
healthcare worker to enact evidence-based principles of care to prevent patient harm and most
clinical risks originate directly from defects or insufficiencies in the healthcare system (Adibi,
Khalesi, Ravaghi, Jafari, & Jeddian, 2012). Systematic methods of preventing and managing
delirium can prevent harm. Clinicians are the advocates for patient safety and can advocate for a
systematic delirium pathway with a DRPM used to triage preventative interventions. This would
require development of the care pathway, policy changes, education to staff, and data collection
and analysis on implementation effects. If DRPMs are used, clinicians, nurses, and hospital
administrators will be part of the creation of a new paradigm, a shift in the care of a hospitalized
at-risk patient, with the potential to improve patient outcomes and decrease the cost of delivering
healthcare.
For clinicians delirium has many consequences like the patients inability to consent for
procedures, learn about personal healthcare interventions, participate in therapies, or any
cognitive interaction. Family members need to be contacted for consent and illness education
which may result in a delay in care or extended hospitalizations. Patients with delirium are
unable participate in meaningful activities in therapy, provide self-care, or to comply with
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medical management, increasing their risk of adverse outcomes. Delirious patients may
inadvertently cause personal trauma while pulling at or removing medical devices such as
intravenous catheters, Foley catheters, oxygen assistive devices, and monitoring equipment
increasing the risk for infections, bleeding, and urinary incontinence; thus, nursing care increases
as well as the use 1:1 sitters. Hallucinations and delusions set a patient up for unintentional selfharm or caregiver harm, for which physical or medicinal restraints may be applied for safety,
again increasing nursing care, sitters, and added workload documenting safety.
Requiring another assessment tool would increase workloads that are already heavy, but
employment of an automated delirium risk prediction model would mitigate additional work for
assessments. The risk level will alert nurses to tailor interventions to meet a patient’s health
needs based on patient specific risk factors. Bedside nurses tailor care to meet patient needs as
part of their nursing processes. They are in a special position to assess for delirium risk, discover
onset of delirium, notify providers of the onset, and intervene with the tailored evidence-based
preventative strategies. An example is enacting a tailored plan to treat a disturbed circadian
rhythm due to nursing activities over-night. The nurse modifies timing of assessments and
interventions, matching a patients sleep cycle; this may require calling clinicians to allow for
decreased checks on vital signs or overnight nursing assessments. A second example is
mitigating the effect of sensory deficits by encouraging the use of hearing aids or glasses during
the day.
A clinicians role varies from a nurses role in that in response to level of risk for delirium
a clinician would weigh the risk and benefit of procedures, medical tests, and medications
against the potential triggering of iatrogenic delirium. If the onset of delirium is reported or
discovered, clinicians must respond with a full medical work up, to determine differential
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diagnoses and choose the appropriate medical interventions to treat the underlying cause.
Clinicians can consult geriatricians, psychiatry, physical therapy, and pharmacy for their
recommendations on preventative strategies and management of patients delirium. Directing
nursing non-pharmacological management and ordering frequent assessments on mentation and
ability to perform ADLs.
This integrated literature review has far-reaching implications for healthcare's ability to
prevent the harmful effects of delirium by improving recognition of a patients risk for delirium,
understanding that it is often preventable through the implementation of delirium prevention
interventions, and prevention of delirium improves the quality of care to every hospitalized
patient by decreasing adverse events associated with it. The World Health Organization (WHO)
defines health as "a state of complete physical, mental and social well-being and not merely the
absence of disease or infirmity (“Constitution”, para 1.). The World Health Organization defines
health promotion as the process of “enabling people to increase their control over and improve
their health” (What is health promotion, para. 1).
According to the IHI, the triple aim for healthcare is an approach to optimize healthy
system performances by improving the patient experience, health of populations, and reducing
the per capita cost of care (IHI, 2018). The role of healthcare providers is to maintain health,
thus preserving the quality of life. Delirium negatively impacts patient and family healthcare
experiences as it results in poor health outcomes and increases the cost of healthcare.
Summary of Conclusions, Recommendations, and Implications for Nursing
The aim of using a DRPM in clinical practice is to stratify the risk for incident delirium
allowing clinicians to target those at the most risk with the preventative interventions. One
impact study showed implementation of a delirium prevention pathway, including a DRPM to
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triage the interventions, allowed for efficient use of resources. This implementation study
reported a decrease in length of stay, 30-day readmission rates, and severity of delirium. The
literature shows that DRPMs are able to stratify the risk of delirium and when included in a
preventative care pathway effectively mitigate some repercussions of incident delirium.
Automated models have been developed in response to the barriers of adoption and
implementation of DRPMs. After integration in computerized charts, automated models are the
most feasible models because the result is available to the provider without additional time added
to their workflows. The electronic versions of the e-NICE by Rudolph et al. (2016) and the
Wong et al. (2018) models were statistically superior to all of the other models; they are
technically complex, with the GBM containing hundreds of predictors mined from the
computerized charting system (Wong et al., 2018). The Wong et al. study notes that if requested
other researchers or healthcare systems seeking quality improvement of delirium care can request
the computer program that the researchers developed and allow the use by another healthcare
system. The DSS (Pendlebury et al., 2016b) shows promise for use in healthcare facilities where
integration into an electronic medical record is not possible with its feasibility and accuracy of
stratification.
The AWOL and e-Nice tools are the only tools reported in research that are clinically
employed at this time. The AWOL tool was employed as part of a care pathway and was studied
in three follow up studies, the Brown et al. (2017) impact study, Pendlebury et al., (2016a), and
the Wong et al. (2018). It is available in the computer application called MdCalc, but this is not
tied into the computer systems and clinicians still need to actively seek the risk score, again
creating unreliability. The e-NICE tool is in current use in clinical practice at the VA medical
centers, alerting clinicians of the patients at highest risk.
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The Gradient boosting machine by Wong et al. (2018), is a tool with the highest
sensitivity and specificity of all delirium risk stratification models. It is an electronic model that
automatically uses data abstraction to electronically stratify every admission for delirium risk. It
contains over 300 predictors, thus is the most comprehensive, and has the highest AUC of any
delirium risk prediction model at .855, however this model is very complex. Neither the GBM
nor the e-NICE have been implemented in tandem with a delirium prevention bundle.
Gaps in practice include lack of implementation and impact studies to provide clinical
evidence of the effectiveness of the models. There are no studies showing which interventions to
employ at each risk level which may increase the effectiveness and decrease use of unnecessary
resources. Generalization of DRPMs are difficult related to their narrow focus of population and
the fact that some are not externally validated. DRPMs are created to aid clinical decision
making of healthcare providers, however, no studies examining their effect on clinical decisionmaking exist.
The primary studies of the DRPMs show validated statistical proof that they have the
ability to stratify risk. The impact and implementations studies provide literature supporting
their use within a care pathway. HELP interventions have shown to decrease delirium rates and
NICE guidelines recommend similar interventions without the use of hundreds of volunteers.
The main recommendation is to implement a full delirium prevention pathway. A DRPM will
allowing triaging of the interventions within the pathway to deliver necessary preventative care
to decrease risk, decrease adverse outcomes associated with delirium, and ultimately improve the
quality of care given to patients. The process and result of implementation should be studied and
published to begin to close the gap in evidence of clinical effectiveness of their ability to stratify
risk, triage interventions, and prevent delirium cases and other negative implications of delirium.
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In summary, optimal models must have the ability to discriminate, calibrate, and are
validated in the clinical practice setting adopting the model. To be useful in practice (feasible),
predictors must be readily available at the time of admission, or shortly after (same day), and
cannot require additional medical testing or complex assessments. The more recently created
and validated primary delirium risk prediction models have proven feasibility in their less
complicated predictors. The risk assessment must be completed as early as possible after
admission to allow for the implementation of preventative measures before insults occur that
further increase the risk of delirium. Delayed risk assessment results in a lost opportunity to
preventative delirium. Improvement in provider reception of a risk prediction model may follow
the recommendation for an automated risk prediction score because of the liberation of a
provider's time. These automated models also show a statistical improvement in stratification
accuracy compared to the non-automated models.
Delirium is a medical emergency with consequences of death and disability, similar to a
stroke or a myocardial infarction. There are no cures for delirium; healthcare providers must take
action in the fight to prevent its onset. We cannot wait for the creation of the perfect model or
care pathway. The healthcare system continues to dismiss evidence that a care pathway (such as
the ABCDEF bundle or the HELP) can prevent delirium, which results in patient harm, family
burdens, and rising healthcare costs.
The current practice of assessing risk by clinical intuition and experience allows for vast
variations in practice. As evidenced by the high delirium rates in our acute care facilities it is also
very inefficient. Therefore, a systematic method needs to be employed to consistently stratify the
risk of every patient admitted to a hospital. The recommendation for application in clinical
practice settings is to develop and implement complete delirium prevention, treatment, and
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management care pathway. A DRPM can be employed to triage the hospital's limited resources
to those of greatest need.
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Appendix
Table 1
e-NICE: Rudolph et al., 2016
Risk Factor
Cognitive Impairment
(positive if one term
present)
Sensory Impairment
(positive if one term
present)
Dehydration (Positive
if BUN/Creatinine ≥18)
Severity of illness
(positive if 2 terms
present)

Delirium Risk
Low
Medium
High

Abstraction Terms
Dementia, Alzheimer’s Disease, Poor Historian, Memory loss,
Unarousable, Uncooperative, Demented, Delirium, Change in
mental status, confused, Encephalopathic, Disoriented,
Lethargic, Obtunded, Stuporous, Combative,
Visual loss, Blindness, wears glasses, Hearing impairment,
Hard of Hearing, Wears hearing aids, Presbycusis
BUN, Creatinine
Age>60, Metastatic Cancer, Lymphoma, Leukemia, AIDS,
RR > 25, Systolic blood pressure <100 mmHg, Pulse >120,
Creatinine >2.0, Albumin < 2.5, total Bilirubin > 2.9

Risk Factors
0
1-2
3-4

Table 2
Martinez et al.,2012
Variable
Age ≥85
Dependent in 5+ ADLs
• Grooming
• Dressing
• Toileting
• Ambulation
• Bowel/bladder control
• Feeding
Psychotropic medications
• Antidepressants
• Antidementia drugs
• Antipsychotropics
• Anticonvulsants
• Benzodiazepines
Total >1 High risk

Total

Score
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Table 3
AWOL: Douglas et al., 2013
Variable:

Score

Age ≥ 80 =1
Ability to spell WORLD backward=1
Disorientation to place = 1
Nurse rated illness severity = 1
Total >2

Table 4
CHAID Decision Tree Model: Kobayashi et al., 2013

Age ≤ 50
QUITE low risk

NO delirium
history

Non-malignancy
LOW risk 1

Age >50 ≤75
Independent ADLs
LOW risk 2
Hospital admission
Age >75

Malignancy
Moderate risk
Delirium history
QUITE High Risk

Dependent ADLs
HIGH Risk
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Table 5
Delirium Prediction Score (DPS): Carrasco et al., 2014
DPS= (5 X BUN (mg/dl)/Creatinine (mg/dl) ratio) – (4 x Barthel Index)
Note: the cut point is -160

Table 6
DRPM Comparison and Model Update: Pendlebury et al., 2016a
Original author:

Variable:

Martinez et al.
Age ≥85
Functional Dependence
• Living at a care center or at
home with homecare
Diagnosis of Dementia
Total >1
Isfandiaty et al.

Cognitive Impairment =3
Functional Dependence = 2
• Living at a care center or at
home with homecare
Infection without sepsis =1
Infection with sepsis (SIRS≥2)= 2
Total >3

Douglas et al. 2013
(AWOL)

Age ≥ 80
Dx of Dementia or low cognitive score
as defined by this study (2 points)
Illness severity (nurse assessment)
Total ≥2

Score
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Table 7
Delirium Susceptibility Score: Pendlebury et al., 2016b
Variable:

Score

Age ≥ 80 =2
Cognitive Impairment = 2
(MMSE <24 or AMTS<9 or known dementia)
Infection =1
Infection with sepsis (SIRS≥2)= 1
Visual Impairment= 1
Total ≥ 5

Table 8
Delirium Prevention Links
Resource

Website

American Nurses
Association Delirium
Prevention Strategies
2016

https://www.nursingworld.org/~4afecf/globalassets/practiceandpolicy/innov
ation--evidence/prevention-best-practices-wg10272016.pdf

National Institute for
Health and Care
Excellence (NICE)

https://www.nice.org.uk/guidance/cg103/evidence/appendix-a-summary-ofevidence-from-surveillance-pdf-6594316238

Health Research &
Educational Trust

https://patientcarelink.org/wp-content/uploads/2018/09/preventing-andmanaging-iatrogenic-delirium-change-package.pdf

The American Geriatrics
Society (post-op delirium)

https://geriatricscareonline.org/

American College of
Critical Care Medicine/
Society of Critical Care
Medicine (SCCM)

https://www.sccm.org/search?searchtext=delirium&searchmode=anyword

The American Association
of Critical Care Nurses
(AACN)

https://www.aacn.org/clinical-resources/practice-alerts/assessment-andmanagement-of-delirium-across-the-life-span
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Table 9
Newcastle-Ottawa Scale for Quality Assessment
Study

Selection (3)

Comparability (2)

Martinez et al.,
2012

**(method to
determine
prevalent
delirium not
stated)

**(ConfoundingIM MD to dx
delirium, low rate
of delirium)

Douglas et al.,
2013

***

Carrasco et al.,
2014

**(refers reader
to a previous
study for
baseline
characteristics

Outcome/Exposure
(1)
*(Follow up not
necessary in this
study type)

Total
score
5/7

**(potential
tautology-parts of
CAM for risk
factors)
**(Confoundinglower rates due to
delays in
admission)

*

6/7

*

5/7

Kobayashi et
al., 2013

***

**

*

6/7

Rudolph et al.,
2016

***

**

*

6/7

Pendlebury et
al, 2016b

***

**(Cofoundingboth a prognostic
and diagnostic
model)

*

6/7

**(ages not rep.
of typical
age18+ 46/114
delirious ages
18-65)

**(Confoundinglow rate of
delirium r/t ages
18+ all included)

*

5/7

Wong et al.,
2018
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Table 9, Cont.
Newcastle Ottawa Scale for Quality Assessment Explanation.
Selection One max: 4 stars
1) Representativeness of the exposed cohort
a. Truly representative of the average delirium study in the community*
b. Somewhat representative of the average in the community*
c. Selected group of users (e.g., nurses, volunteers)
d. No description of the derivation of the cohort
2) Selection of the nonexposed cohort
a. Drawn from the same community as the exposed cohort*
b. Drawn form a different source
c. No description of the derivation of the nonexposed cohort
3) Ascertainment of exposure
a. Secure record*
b. Structured interview*
c. Written self-report
d. No description
4) Demonstration that outcome of interest was not present at start of study
a. Yes*
b. No
Comparability (max: 2 stars)
1) Comparability of cohorts on the basis of the design or analysis
a. Study controls for _________ [select the most important factor]*
b. Study controls for any additional factor*
Outcome (max: 3 stars)
1) Assessment of outcome
a. Independent blind assessment*
b. Record linkage*
c. Self-report
d. No description
2) Was follow-up long enough for outcomes to occur
a. Yes*
b. No
3) Was there adequacy of follow-up of cohorts
a. Complete follow-up = all subjects accounted for*
b. Subjects lost to follow-up unlikely to introduce bias (e.g., small number or percentage lost)
c. No statement
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Table 10
Levels of Evidence Description
Level of
Evidence
I

II
III
IV
V
VI
VII

Description
Evidence from a systematic review or meta-analysis of all relevant RCT;s (randomized controlled
trial) or evidence-based clinical practice guidelines based on systemic reviews or RCTs or three or
more RCTs of good quality that have similar results.
Evidence obtained from at least one well-designed RCT (e.g. large multisite RCT)
Evidence obtained from a well-designed controlled trial without randomization (i.e. quasiexperimental).
Evidence from well-designed case control or cohort studies.
Evidence from systematic reviews of descriptive and qualitative studies (meta-synthesis).
Evidence from a single descriptive or qualitative study.
Evidence from the opinion of authorities and /or reports of expert committees.

Note: This level of effectiveness rating scheme is based on the following: Ackley, B.J., Swan, B. A., Ladwig, G., &
Tucker, S., (2008). Evidence-based nursing care guidelines: Medical-surgical interventions. (p. 7). St. Louis, MO:
Mosby Elsevier
Note: In the literature review tables (Table 12), the single asterisks * indicate studies of the models critiqued and
compared in this literature review. The double asterisks ** indicate supporting studies for the DRPM models
(Table 12).
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Table 11
Delirium risk prediction model and supporting studies: Level of Evidence and Study Design

Delirium Risk
Prediction Model
AWOL

Douglas et al., 2013

Level of Study design
Evidence
IV
Prospective cohort

Wong et al., 2018

IV

Retrospective cohort

Pendlebury et al., 2016a

IV

Prospective cohort

Brown et al., 2017
Rudolph et al., 2016

IV
IV

Retrospective cohort
Prospective cohort

Halladay et al., 2018
Gradient Boosting
Wong et al., 2018
Machine
CHAID Decision Tree Kobayashi et al., 2013

IV
IV

Retrospective cohort
Retrospective cohort

IV

Retrospective cohort

Delirium
Susceptibility Score
Isfandiaty et al.

Pendlebury et al., 2016b

IV

Isfandiaty et al., 2014

IV

Prospective
observational audit
Retrospective cohort

Pendlebury et al., 2016a
Martinez et al., 2012

IV
IV

Prospective cohort
Prospective cohort

Pendlebury et al., 2016a
Carrasco et al., 2013

IV
IV

Prospective cohort
Observational cohort

e-NICE

Clinical Prediction
Rule
Delirium Prediction
Score

Supporting evidence

73

Table 12
Literature Review Tables

Citation

Purpose/
Objectives

Study
population/
Sample/
Setting

Study Design/
Methods/
Major Variables/
Instruments and
Measures

Result(s)/
Main Findings

Implications
/critique

Comments
Themes

Level of
Evidence

*Rudolph, et
al., 2011
Validation of a
medical
record-based
Delirium risk
assessment

Improve ID
of pts at
high risk
for
delirium,
develop a
chart
abstraction
tool and
validate the
tool against
clinical
expert
diagnosis

100 VA
patients,
medical
units,
One center,
age 65 and
over

Prospective cohort
based on the previous
Inouye (1993)
developed prediction
rule that included
cognitive impairment,
sensory deficits,
severity of illness
(APACHE II), and
BUN: Creatinine ratio.

-Chart abstraction took 2
minutes 19 seconds
-Delirium + in 23% with
incident in 14% (prevalent
9%)
-cognitive impairments
correlated low MMSE score
-Higher Charlson
comorbidity index scores
correlated with chart
identified severe illness.
59% had sensory
impairments.
-more risk factors correlated
with delirium dx was
statistically significant (X² =
9.2, df=2, P=0.01.
C statistic 0.65, 95% CI=
.54-.76
prevalent delirium removed
then the rate was not
significant (X² = 1.3 , df=2,
P=0.53.
C statistic 0.56, 95% CI=
.42-.74

statistically
significant with
prevalent delirium
only

Statistically
insignificant

IV

Variable-delirium as
an outcome
Instruments:
MMSE-geriatrician
performed on
admission and daily to
Dx based on DSM-IV,
Charlson Comorbidity
Index, (not APACHE
due to increase need
for labs costly)
BUN:Creat ratio
Chart review for
sensory deficits and
cognitive impairments

- simplicity to use
-automated chart
abstraction tool to
rate delirium risk
for real-time
decision support
to prompt targeted
interventions.
-Limitations were
sample size and
setting

Dx of delirium
by a geriatrician
MMSE daily is
time consuming
rates of delirium
correlate with the
study by Inouye
et al. (1993).
Charlson
Comorbidity
Index not as
effective as the
APACHE II.
Generalizability
limited due to
single setting,
white male
Predict prevalent
delirium best.

74

Citation

Purpose/
Objectives

Study
population/
Sample/
Setting

Study Design/
Methods/
Major Variables/
Instruments and
Measures

Result(s)/
Main Findings

Implications
/critique

Comments
Themes

Level of
Evidence

Isfandiaty, et
al., 2014
Incidence and
Predictors for
Delirium in
Hospitalized
Elderly
patients: a
Retrospective
cohort study.

Determine
incidence
and
predictors
for
delirium.

457 patients,
aged 60 and
over, in an
internal
medicine
dept and
acute
geriatric
ward in
Indonesia.

Retrospective cohort
-March thru April of
2011.
-prevalent delirium
excluded
-Variables in the
development cohort
included: 12 predictors
derived from previous
studies: age, gender,
hypoalbuminemia,
anemia,
anticholinergic drugs,
decrease in functional
status (Barthel index),
stroke, metabolic
disturbance, heart
disease, infection with
and without sepsis,
and hypoxia
-Md DX delirium- no
screening tools noted.
Data analysis via
SPPS 17.0 with SD
-Cox hazard: to
determine indep
predictors.
-Missing data: imputed

87 pts experienced delirium
out of 475 patients=18.8%
--no delirium= 75.5%- mean
survival is 11.8 days
without
-59.3% of delirium
occurred within the first 3
days, and 81.4% within the
first 7 days of admission.

-risk of delirium
based on days in
pt.
-Simple
prediction model
for incidence
delirium in the
first 14 days of
admission
-this study shows
infection is risk
-Cognitive
impairment as
risk-this study
backs this up.
20.2% of pts had
cognitive impair.
-Used 2 cognitive
predictors could
cause Tautology
(cog andADLs)

Cannot locate
model to apply
to patient, no
explanation of
application

IV

Develop a
prediction
model for
delirium in
an
Indonesian
hospital
population.

Missing variables dealt with
by Estimation and
Maximalization (EM) to
impute missing data to
maintain study power- this
method is preferred to
excluding data.
Cox proportion hazard
method showed infection,
decreased function status
and cognitive impairment
the 3 indep predictors.
Logistic regression used to
determine model based on 3
predictors.
Hosmer-Lemeshow test P
value 0.066 and AUC 0.823:
CI 95% 0.776-0.877)

No validation
internal or
external
Nice use of
statistical models
to determine
weights of
predictors,
however this is
not explained nor
is how we derive
a score
Indonesia study,
unable to
generalize to
general
population of
mixed races
Note that
infection with
sepsis was the
greatest rated
predictor.
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Citation

Purpose/
Objectives

Study
population/
Sample/
Setting

Study Design/
Methods/
Major Variables/
Instruments and
Measures

Result(s)/
Main Findings

Implications
/critique

Comments
Themes

Level of
Evidence

*Marinez, et
al., 2012.
Derivation and
Validation of a
Clinical
Prediction
Rule for
Delirium in
Patients
Admitted to a
Medical Ward:
an
Observational
Study
(Clinical
Prediction
Rule)

Develop
/validate a
clinical
prediction
rule for
patients
admitted to
an internal
medicine
unit based
on easily
identifiable
measures
available
on
admission

Hospital in
Spain

Single Prospective
Cohort original study

Used the Hosmer
Lemeshow test

Outcome: delirium
dx: CAM
18 or over, May 1stJune 30th, 2008 and
2009
Admitted to medical
units.
Independent
researchers reviewed
charts for delirium
with dx by MD

ROC curve analysis

Ease of use
would increase
the Feasibility of
use upon
admission

IV

397 total
patients
Derivation
cohort:
Mean age
75.9 years
Incidence of
delirium
13%

3 independent risk
factors were age
85 or older,
dependent in 5 or
more ADLs, and
taking antipsychotropic
medications

Validation model
predictors: age 85 or
greater, level of
dependence (more
than 5 areas of
dependency)
, psychotropic
medication (2 or
more)- each one point

Those in the Validation
cohort were significantly
more dependent for ADL’s
validation cohort the AUC
is 0.85
-classify around 53% of this
cohort as high risk, limiting
interventions to this 53%,
covering 93.4% that did
develop delirium.

predisposing
factors are mostly
related to
degenerative brain
disease, but
triggers are
related to
hospitalization
insults, none of
the later are
included in this
risk model.

For resource
utilization when
applying costly
interventions this
model is too
general and
includes more
than 50% of the
population as
high risk

302 total
patients
Validation
cohort:
mean age
75.8 years,
Incidence of
delirium
25%

Final model: result
positive if 1 or more is
the score.

2x2 table sensitivity of
93.4%
CI 85- 97.2%
specificity 60.6%
95%CI: 54.4- 66.8%
PPV 44.4%, 95% CI 36.952.1%
NPV 96.5% -95% CI-9298.5%

DX of delirium cases may
still have been missed as an
internal medicine md dx
it/not a psychiatrist

Limitation: Dx of
delirium by IM
MD and not a
psychiatrist thus
some patients may
have been
undiagnosed.

Predict prevalent
delirium best.

Basic model, all
on predictors not
precipitating
factors.
Oversimplificatio
n causing
decreased
specificity and
lower PPV
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Citation

Purpose/
Objectives

Study
population/
Sample/
Setting

Study Design/
Methods/
Major Variables/
Instruments and
Measures

Result(s)/
Main Findings

Implications
/critique

Comments
Themes

Level of
Evidence

*Douglas, et
al., 2013.
The AWOL
Tool:
Derivation and
Validation of a
Delirium
Prediction
Rule

Develop
and
validate a
tool to
predict
likelihood
of
developing
Delirium

2 academic
and one VA
medical
centerstrength.

Prospective cohort
study
-excluded prevalent
delirium after
adjustments

- research
assistants and a 4th
year medical
student screened

Ease of use

IV

May 2010Nov 2010
and October
2011-March
2012

CAM to assess for
outcome of delirium
within 6 days of admit

Predictors entered into
stepwise logistic regression
analysis and ID’d 4 indep.
Predictors of delirium in the
derivation cohort.
Each assigned a value of 1
pt.
The higher the score the
higher the rates for delirium
in the derivation cohort.
40% of the patients in risk
category 3-4 developed
(P<0.001) delirium, and 0 in
the 0 score.
Validation cohort occurred
at the VA- more male than
the derivation cohort.

Adults over
the age of 50
admitted to
medical
units
without
delirium at
time of
admission
(no
prevalent
delirium
included in
this study)
Derivation
cohort-209
Validation
cohort- 165
Medical and
neuro pts

4 items were assessed:
Age ≤80, Failure to
spell WORLD
backwards,
DisOrientation to
place, high nurse rated
ilLness severity
(AWOL)
Statistical significance
was derived in both
cohorts (P <0.001 in
derivation and in
validation cohort
P<0.025
AUC derivation cohort
was 0.81 (95% CI
0.73-0.90) and
Validation cohort 0.69
(95% CI 0.54-0.83)showing moderate
clinical usefulness.

Completed in <2 minutes by
RN staff- developed for
bedside RN use!
This tool characterizes
medical pts at risk at the
time of admission and could
be used in trials of delirium
prevention, that will include
impact studies.

VA- more males
than derivation
cohort.
The validation in
a VA setting is
also clinically
significant as the
AUC remained
adequately high
proving clinical
usefulness.
-external
validation of a
larger cohort is
needed to
determine why 0
were delirious in
level 4, is the tool
sensitive and
specific – should
show higher %
with delirium in
this level.

Bedside RNs
assess in daily
routine
No additional
labs or intricate
assessments
CAM to assess
for outcome
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Citation

Purpose/
Objectives

Study
population/
Sample/
Setting

Study Design/
Methods/
Major Variables/
Instruments and
Measures

Result(s)/
Main Findings

Implications
/critique

Comments
Themes

Level of
Evidence

*Kobayashi, et
al., 2013
A Prediction
Rule for the
Development
of Delirium
among
Patients in
Medical
wards: Chisquare
Automatic
Interaction
Detector
Decision Tree
Analysis
Model
(CHAID)

Predict
delirium in
pts in
medical
wards by
the CHAID
Model

2400 pts in
derivation
group
1170 in
validation
group

-Retrospective cohort
study
2009-10 at St. Luke’s
community hospital
Tokyo Japan. Internal
med unit
-Predictor variables for
CHAID(5): hx of
delirium, dementia,
aged, underlying
malignancy, impaired
ADL’s, ETOH
-Predictor variables for
logistic(5) Age, hx of
delirium, dementia,
malignancy, EtOH
abuse, and ADL
impairment
-Providers and nurses
monitored for delirium
Dx of outcome made
by DSM IV
-Data mining
technique-CHAID and
a logistic regression
were compared to find
the best model.
-SPSS software used
for analysis except for
CI computed by Stata
version10

CHAID Validation AUC
0.82 (95% CI:0.77-0.86)

Significance level
can be modified
to fit number of
comparisons.

Pts monitored by
RN and MDs for
delirium on set,
however no tools
used like the
CAM or the
NuDESC to
determine
changes.

IV

Age≥18

Divided into 6 levels of risk,
quite low, low 1, low 2,
moderate, high, and quite
high- when broken down the
delirium rates climbed as
each level increased
The logistic regression
model showing all variables
included to be significant
Validation AUC =0.79
(95% CI:0.72-0.86)
Ease of use noted.
3.8% developed delirium in
derivation group, and 4.2%
in the validation cohort

Similar sample to
the derivation
group for
validation can
lead to elevated
rate of reliability
Necessary to
externally validate
a tool such as this

Combine levels
to absorb the 2
highest risk
levels and the 2
lowest risk levels
CHAID can be
broken down to
ages and a score
for children can
be derived too.
This tool is noted
to be easy and
flexible with use
of data
One of the only
tools to include
dementia!

78

Citation

Purpose/
Objectives

Study
population/
Sample/
Setting

Study Design/
Methods/
Major Variables/
Instruments and
Measures

Result(s)/
Main Findings

Implications
/critique

Comments
Themes

Level of
Evidence

Gonzalvo, et
al., 2017
The
development of
an automated
ward
independent
delirium risk
prediction
model.
(DEMO)

Develop
and
automated
ward
independen
t delirium
risk
prediction
modelexclusively
from
electronical
ly available
risk factors
and
increase the
ability to
be part of
the clinical
decision
support
system to
aid
providers
in initiation
of delirium
prevention

Age ≥60
Admitted to
hospital, no
dx of
delirium
within the
first 24
hours (no
prevalent
delirium)

Retrospective cohort
study

Compared 2 developed
prediction scores. Addition
of clinicals was irrelevant to
the accuracy of the
prediction model, thus they
opted for the simplest model
containing only age and
Medications

Some studies state
prevalent delirium
is onset within 48
hours here it is 24
hours.

Study done in
Netherlands in
one setting.

IV

-Only one
setting for
derivation of
this modelhospital in
Netherlands
Control
group= 1066
pts
Delirium
group
225/646 pts
included-!

-Logistic regression
analysis with a p<0.05
included in
multivariable model as
-Outcome- MD
documentation of Dx.
Use of Delirium
Rating Scale and
Delirium Obs scale to
aid in Dx. No use of
DSM criteria.
Medication and age
model preformed as
well as the full model
to suggested validation
of the medication
model as it requires no
labs.

AUC of the full predictive
model-0.78
AUC of the medication
model-0.76- addition of lab
values did not provide
additional benefit and many
lab values missing-state that
this shows the model is not
overfit

Not generalizable
due to study
setting.
Not a validation
study
Medications used
in this country
may vary greatly
than others thus
may not be
predictors of
delirium in other
settings
Over simplistic
models can cause
overfitting
equaling elevated
AUC score and
predictive
capability

EMR used to
evaluate risk
prediction in
these models.
Both appear
relative;
however, they
note that risk
factors that are
typically
significant in
other studies are
not significant
indicators in this
study. Which is
concerning for
accuracy of data
and were pts
accurately dx
with delirium?
Dx based on
DRS and DOS,
whereas most
studies use CAM
or CAM-s
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Purpose/
Objectives

Study
population/
Sample/
Setting

Study Design/
Methods/
Major Variables/
Instruments and
Measures

Result(s)/
Main Findings

Implications
/critique

Comments
Themes

Level of
Evidence

Pendlebury, et
al., 2016a.
Delirium risk
stratification
in consecutive
unselected
admissions to
acute
medicine:
validation of
externally
derived risk
scores

Determine
reliability
of 4
externally
derived risk
scores in a
consecutive
cohort of
older acute
care
medicine
patients

308 Adults
aged ≥65,
admitted in
and 8-week
period in
2010, 2012.

Prospective cohortOxford University
Hospital
-Model update study
of 4 existing tools
- CAM and DSM IV
criteria.
-Cohort 1 used MMSE
within 24 hours <24
positive cog impairs
Cohort 2 used AMTS
<9 positive cog
impairs
-Delirium rates noted :
28/95 incident.
-prevalent and incident
delirium
-Gathered data on
demographics, admit
complaint, potential
risk factors, hx of
dementia,
vision/hearing deficits,
VS, SIRS score.
-acute medicine pts.
-Sensitivity,
specificity, PPV, NPV
were measured as well
as the AUC.

Studies included:
Inouye et al., 2007
Martinez et al., 2012
Isfandiaty et al., 2012
Douglas et al., 2013

Superior study in
the framing and
reasoning for use
of risk assessment
tools: decreasing
missed dx,
focused
interventions

Some tools
altered to fit data
obtained by this
patient group
such as no
spelling world
backward instead
if confusion
present score
here was a 1.

IV

Published 1st
and the next
article adds to
this.

externally
validate
and
compare
clinically
applicable
risk scores
within the
same data
group in an
external
center
during
usual
routine
clinical
care.

Unable to include Carrasco
et al, 2014, no ability to
complete Barthel index
Results:
AUC 0.73-0.83 for incident
delirium.
All scores performed better
than chance,
-no superior tool is found all
relatively equivalent.
Noted that these can
facilitate targeting of
multicomponent
interventions.
May help recognize risk,
improve dx of delirium.

Noted some
assessments
required nonroutinely avail.
Data which
required
simplification (i.e.
WORLD spelt
backward
eliminated from
AWOL).

Externally
validated 4 tools
in one study.
More validation
in differing
cohorts is
needed.
Interested to see
if there is an
impact study to
follow this study.
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/critique

Comments
Themes

Level of
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*Pendlebury,
et al., 2016b.
Delirium risk
stratification
in consecutive
unselected
admissions to
acute
medicine:
validation of a
susceptibility
score (DSS)
based on
factors
identified
externally in
pooled data
for use at entry
to the acute
care pathway.

Derivation
and
validation
of a
simplified
delirium
susceptibili
ty score for
use on
admission
in clinical
practice on
older acute
medicine
patients.

Age ≥65
308 patients

-Prospective cohort
-September to Nov
2010 and again AprilJune 2012
-Screened for outcome
with CAM, dx with
DMS-IV by MD
-Tripod guidelines
followed for
development of a
prediction tool.
-NICE Guidelines for
factors
Reliability determined
by:
AUC was 0.81 (0.70–
0.92), for incident
delirium;
odds ratios (ORs) for
risk score 5–7 versus
<2 were 17.9 (5.4–
60.0), P < 0.0001 for
any delirium, 8.1 (2.2–
29.7), P = 0.002 for
prevalent delirium,
and 25.0 (3.0–
208.9) P = 0.003 for
incident delirium, with
corresponding relative
risks of 5.4, 4.7 and
13.

Detects prevalent and
incident delirium

Higher scores
indicative of
increased frailty,
high care needs,
and poor
outcomes
indicating good
face validity of
this tool

Simplicity could
be automated in
the EMR.

IV

Preformed as well
as other prediction
scores previously
compared in the
study above.

Pulled in
relevant studies,
guidelines, and
framework for
building a
prediction model

Delirium
Susceptibility
Score (DSS)
developed here

Builds on
previous
studies
from this
main
author
including a
study on
risk factors
in 2015.

31% dx with
delirium,
(67/95 with
prevalent
and 28/95
incident)

Pragmatic/Simple tool.
DSS had higher AUC than
any other previously tested
model (previously tested in
this cohort), but once AUC
accounted for the correction
for multiple comparisons
the AUC was generally
comparable.
Simplified form of the
previous scores- derivation
of new prediction score in
this article.
Each risk factor was
removed, and AUC was
analyzed to determine
necessity of the risk factors.
Vision is the only one that is
non-significant, however
removal of age >80 was
removed AUC improved to
0.80 (0.74-0.86) for any,
0.74 (0.67-0.81

New score
developed based
on multi center
risk factors and
previous studies
derived based on
data obtained by
the cohorts.
Statistical analysis
in this study was
robust due to
TRIPOD.

Developed as a
diagnostic and
prognostic
model- could it
dx delirium?
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**Brown, et
al., (2017).
Predicting
inpatient
delirium: The
AWOL
delirium riskstratification
score in
clinical
practice.

efficacy of
the AWOL
score in
clinical
practice
with
bedside
RNs
assessing at
admission
on all
patients
over the
age of 50.

University
medical
center
Neuro and
medical
patient
population

Retrospective cohort /
IMPACT study

Variable was addition
of prevention plan for
a score of ≥2.

AUC for incident delirium
only was 0.73 (95% CI
0.60-0.85).

Based on the
AUC and
specificity and
sensitivity scores
this model has
successfully
stratified patients
into high and low
risk- resources
can be allocated
when needed.

Less sensitive
due to the factors
do not account
for all the risk
factors of
delirium or
account for all
cases.

IV

CAM to screen for
delirium outcomeevery shift

Those with AWOL score of
0 =5.45% delirious with
3.11% with incident
delirium. Score of ≥2 60.5%
delirious, with 25% having
incident delirium.

Compared outcomes
(delirium) before and
6 mo. after
implementation of the
delirium care pathway
which included
interventions aimed to
prevent delirium.

incident delirium only group
sensitivity 50.0% and
specificity 89.2%.
PPV-25%
NPV-96.1%

AWOL vs
normal care
2014-15.

Admit dates
April 2014March 2015
Retrospectiv
e cohort data
pulled from
charts from
Nov 2013
-800 charts
were
randomly
selected,
797 were
included in
final.
Ages 50 & >
scoring 2 or
more
considered
high risk
and
prevention
plan
initiated.

ROC curve analysis
completed, sensitivity
and specificity noted.

Only 46% of patients were
scored! Need for increased
education to staff prior to
next IMPACT study.

Due to less
sensitivity CAM
or assessment
monitoring should
continue to be
assessed to
prevent missing
diagnosis.
Predicts both
incident and
prevalent delirium
thus needing to
eval more closely
those ID’d @
higher risk to
ensure delirium is
not present.

Possibly seeing
decreased rates
of incident
delirium because
of the
implementation
of the care
pathway.
Not applicable to
surgical
populations
(would need
validation and
re-calibration)
Also validated
below in
Pendlebury
study.
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*Carrasco, et
al., 2014.
Development
and validation
of a Delirium
Predictive
Score in older
people

Develop
and
validate a
predictive
score upon
admission
for
INCIDENT
delirium in
medically
admitted
patients
over the
age of 65.

Inclusion:
adults
hospitalized
≥65,
admitted to
general
medicine
unit

Observational
prospective cohort- to
develop and validate a
score.

The authors devised a
formula to result the
Delirium Predictive risk
Score (DPS) =
(1370 X BUN
(mmol/l)/creatinine (µmol/l)
ratio)- (4 x Barthel Index).

Use of CAM
should be
increased to
minimally daily
with best practice
once per shift.

Simple
measurements,
statistically
sound.

IV

(DPS)

University
affiliated
hospital
Inclusion:
Exclude
aphasia,
coma, or
inability to
perform cog.
Eval.
Validation
cohort 104
patients, 12
developed
delirium.
Predictive
performance
AUC was
0.78 (95%
CI: 0.660.90)

CAM within 48 hours
and every 48 hours
thereafter to assess for
delirium
Data collected
included: comorbidity,
illness severity,
functional status and
laboratory data.
Final tool included:
Barthel Index used for
functional status and
BUN to assess for
dehydration. No other
risk factors were found
to be statistically
significant to add to
this design.

Or conventional BUN and
Creatinine measures the
DPS= [5 x BUN
(mg/dl)/creatinine (mg/dl)](3 x Barthel Index)
with cutoff point -160
AUC for development
cohort 0.86 (95% CI: 0.820.91)
For cut off value of -240 & 160 due to its high
sensitivity and specificity.
AUC for validation cohort
0.78 (95% CI: 0.66-0.90)higher than many tools
noted thus far!
+ LR 3.4
-LR 0.16

Language was not
a barrier for
enrollment!
Barthel Index is
noted to be based
on the patients
function status 2
weeks prior to
admission, RN
could assess with
patient or family.
Noted that its
negative LR is
0.16 showing it is
very good a
predicting who
will not develop
delirium allowing
focused
interventions to
those at greater
risk.

Needs further
larger population
external
validation in
various centers
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Gonzalvo, et
al., 2017.
Validation of
an automated
delirium
prediction
model
(DEMO)); an
observational
study

Validate
the DEMO
model that
was
developed
at
Zuyderland
Medical
Center and
uses only
electronical
ly available
data to
predict
occurrence
of delirium.

All patients
admitted to
hospital over
the age of 60
in Sittard
and Heerlen,
Netherlands.
from Jan
2016-Oct
2016
450 patients
included

-Observational study
-over the age of 60
assessed every 24
hours.
-Retrospective chart
review was done to
chart check for
delirium.
-Variables: age,
polypharmacy and use
of antidementia
medications,
antidepressants, antiParkinson’s agents,
anti-diabetic drugs,
analgesia and sleeping
tables
-Applied hospital wide
-Original model AUC
0.770 (95% CI: 0.7360.804)
Sensitivity 78.2%
(tested positive)
Specificity 63.7%
(non-delirious tested
negative)
-DOSS (delirium
observation Screening
Scale) used to
determine delirium-

Excluded all prevalent
delirium

Dx of delirium
based on chart
reviews and audits
for key wordscould cause false
positive and skew
this data.

Weakness, pts is
asked 3
questions prior to
any screening for
delirium is done,
if these questions
are all negative
then screening
for delirium is
not done!
These questions
are not validated
instruments.

IV

Zuyderland
Medical
Center
which was
the
origination
location for
the DEMO
tool.

Sensitivity≥ 0.827
Specificity≥0.779
(better than reported in
original study)
PPV from 43.2% (day 1) to
64.8% on day 5
NPV from 96.9 (day 1) to
93.4% day 5.
AUC- was not tested
Simplified models can result
in overfitting
Medication classes were
included not specific
medications- which may
decrease overfitting

Needs prospective
study that
includes clearer
dx and onset of
delirium
Needs further
validation outside
of this developing
facility and
outside of the
Netherlands.
Focus is mainly
on medications on
MAR the day
prior onset, some
medications have
a cumulative
effect such as
anticholinergics

Single center
study in
Netherlands not
generalizable
without external
validation
Medications
listed not the
same as other
countries
Automated daily
score- Ease of
use!
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**Halladay et
al., (2018)
Performance
of Electronic
Prediction
Tools for
Prevalent
Delirium at
Hospital
Admission

Develop
and assess
a prediction
rule for
delirium
using 2
populations
of veterans
and
compare to
previously
created
rules.

Veterans
Affairs at
118 VA
medical
centers
Inpatient
facilities
Admitted
with CHF
ACS,
Community
acquired
PNA, COPD
D=Oct 1,
2012Sept.30th
2013
V=Oct 1,
2013- March
31, 2014
Delirium
within 24
hours of
admit.

Retrospective cohorts,
x2 derivation and
validation cohorts.
Outcome: delirium
within 24 hours of
admission

Developed and validated
this tool.
Compared this tool to the
eNICE and Pendlebury DSS
2016b with higher
discrimination in this tool
then them.

4 factors for
simplicity

Compares 2
other previously
developed tools,
this tool has
higher AUC but
indicates
recommendation
of additional
RASS or
MYBW tests for
mentation with
may require
more charting
and training of
staff= poor
compliance etc...

IV

Name:
“consolidated
NICE rule”

27625 patients
included in derivation
cohort and 11752 in
validation
Compared to the eNICE and Pendlebury
DSS (2016b)
Predictors: Cognitive
impairment, infection,
sodium level, and age
80 or greater.
Predictors obtained
through the NICE
guidelines and
developed too from
the most independent
risk factors

AUROC, 0.91; 95%
CI:0.91-0.92;p<0.001-high
discriminatory value
Cognitive impairment was
the most important factor
followed by infection,
sodium level, then age.
Delirium upon admission in
devel. Cohort=8.5% and
validation cohort=7.0%
Increasing score was
correlated to increased rates
of delirium in all tools.
3 levels of risk, low (0-2)
Intermediate (3-4) and high
(5-6)

Based on
previously studies
risk factors- NICE
Stratify risk to id
those needing
more cog.
Assessments.
Decrease
unrecognized
delirium to
prevent poor
outcomes
Could be added to
EMR, flags for
teams could be
instituted
9however be
aware of alert
fatigue)
Development and
use of a risk
assessment tool
are recommended
by guidelines.

Used random
forest test for
predictors
Use of NICE
meta-analysis
increases validity
and
generalizability.
HIGH proportion
of men due to
study at VA.
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Sola-Miravete,
et al., 2017

Evaluate
the use of
comprehen
sive
nursing
assessment
to
determine
risk of
delirium in
older inpatients
from a
model of
care needs
based on
variables
measured
easily by
nursing
staff.
2nd ID
predictors
that are
easily
measured
by nurses

≥65, 201314, admitted
to surgical
and medical
units in
Catalonia’s
hospital in
Spain.
150 patients
with
incident
delirium and
304 without
it were
studied

-Case- control study
-CAM-S, assessed
daily
-Virginia
Henderson’s’ needs
model was used
-Indep predictors were
age, incontinence,
urinary catheter,
ETOH abuse, hx
dementia, ability to get
OOB, insomnia, and
social risk. (all
included in final
model).
-Univariate logistic
regression for
associated variables
-Lasso technique to
ensure no overfitting
and generalization
-cross validation x9
was for validity of
model
-Final model,
goodness of fit
(p<0.001) by HosmerLemeshow test.

increase identification of
risk factors through the
nursing assessment for a
care team focus to
personalize plans for
vulnerable patients to
prevent or manage delirium

Use of RNs
typical assessment
could be
expanded to an
EMR tool that
would signal a
best practice alert
to staff and
clinicians –
alerting to high
risk for delirium.

Interesting
variant of a
DRPM

IV

Nursing
assessment as
an effective
tool for the
identification
of delirium
risk in older
in-patients: a
case-control
study

Minimum 3
day admit
Focus in
predicting
INCIDENT
delirium

Highly sensitive, specific,
and high AUC showing
reliability
AUC- the AUC was 0.945
(95% CI: 0.922-0.970)
AUC when applied to test
set was 93.3.
Sensitivity for predicting94.6% and specificity to
predicting absence 89.4%.
Ease of use as RNs already
preform bedside
assessments.
Needs to be externally
validated in similar
populations.
Populations included
surgical and medical
patients (GS Trauma
Urology IM neurology and
other medical specialties.

Used NICE
guidelines and
HELP protocols
to show
relationships
between the
Henderson model
to delirium
prevention
interventions.
Needs external
validation and
prospective cohort
design.

As Dependency
of care increases
so does the risk
of delirium,
therefor any
measure of
dependency may
prove useful in
risk prediction
models.
Increased
dependency is
also an
indication of
fragility.
Would this cross
to CV
populations and
ICU?
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*/**Wong, et
al., 2018
Development
and Validation
of an
electronic
Health recordbased machine
learning model
to estimate
delirium risk
in newly
hospitalized
patients
without known
cognitive
impairment.

Develop
and
validate a
machine
learning
model to
predict
delirium
risk in
patients
without
known
cognitive
impairment
whom are
hospitalize
d

-UCSF
University
hospital
-18 and over
-non-ICU
units
-delirium in
the first 24
hours
excluded.

Retrospective Cohort
-5 machine learning
algorithms to predict
delirium using 345
clinical variables
available in EMR
upon admission:
Demographics, dx,
nursing records, labs,
and medications
BASELINE
comparison AWOL:
AUC 0.678
Exclusions: AMS or
confusion, ICU/ ICU
admit, GCS verbal <4,
ICD9 code for
delirium or psychosis,
NU-DESC positive
CAM≥1.Any
intervene. to prevent
or treat delirium
excluded
Outcome: delirium by
NuDESC or CAM
ICU by nurses every
12 hours.

Gradient boosted Machine
model: AUC 0.855
SET Specificity of 90%
(95% CI:89-90.9%)
Sensitivity: 59.7 (95%
CI:52.5-66.7%)
PPV=23.1 (95% CI:20.525.9%)
NPV=97.8% (95% CI:97.498.1%
Number to screen 4.8% or
191 cases was missed.

This tool can be
adjusted based on
clinical need for
specificity or
sensitivity- would
be great to code
this in a program
to change
recommendations
of which
interventions to
initiate due to
cost/staff
resources.

Complex
computer
analysis.

IV

Compare
AUC to
AWOL
tool
currently
used at this
facility.

-Devel set:
14, 227
patients nonICU
admissions
1/17-8/17
-Training
set: 3996
patients,
8/2017-11/
2017.
Studied
incident
delirium
only.

4 models compared
including the AWOL

This center uses
AWOL already to
screen so use of it
to compare this
tool is unique!
Simple,
computerized
assessment!
Needs external
validation and
possibly impact
studies.

Code provided
on another link
site for others to
validate.
Ease of changing
settings of S/s
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Table 13
Table of Charms Checklist Data

Domain
SOURCE OF DATA
“SYSTEMATIC
REVIEW OF
PREDICTION
MODELS FOR
DELIRIUM IN THE
OLDER ADULT
INPATIENT”
Lindroth et al., 2018

Key items

page #

Source of data (e.g., cohort, case-control, randomized trial participants, or registry data):
1
PubMed, CINHAL, PsychINFO, SocINFO, Cochran, Web of science and Embase were searched from
January 1990 to December 31st 2016.
AIM: Through a systematic review, provide important recommendations on study design for future
delirium prediction models while integrating knowledge gained from the study of both medical and
surgical populations.

Participant eligibility and recruitment method (e.g., consecutive participants, location, number of
centers, setting, inclusion and exclusion criteria)
1

PARTICIPANTS

Inclusion: age >60 years, inpatient hospital setting, developed/validated a prognostic delirium
prediction model, publication dates of 1 January 1990–31 December 2016
Exclusion: alcohol related delirium, sample size less than 50, population noted as Emergency room,
palliative care and hospice, ICU, skilled nursing facilities.
A delirium prediction model was defined as a statistical model that either stratified individuals for
their level of delirium risk or assigned a risk score to an individual based on the number and/or
weighted value of predetermined modifiable and non-modifiable risk factors of delirium present.
Participant description
Inclusion criteria: age >60 years, inpatient, developed/validated a prognostic delirium prediction
model. Exclusion criteria: alcohol-related delirium, sample size ≤50.
Twenty-three delirium prediction models were identified, 14 were externally validated and 3 were
internally validated. The following populations were represented: 11 medical, 3 medical/surgical and
13 surgical, area under the receiver operating curve range from 0.52 to 0.94

1

88

Variables Extracted: study characteristics (study design, population and sample size), outcome
measure (method of identification and diagnosis, frequency and length of screening), model
performance information including the diagnostic accuracy of the delirium prediction models,
calibration metrics and events per variable (EPVs), characteristics of the models (variables used in
model and scoring/stratification system), cognitive measures used in the study and statistical methods
applied for analysis.
Details of treatments received, if relevant-NA
Study date January 1990 to December 31st 2016.
Definition and method for measurement of outcome
Outcomes in this study were: Study characteristics, outcome measure (method to dx, frequency and
length of follow up), diagnostic accuracy of the delirium prediction models, calibration metrics and
events per variable (EPVs), characteristics; variables used in model and stratification system,
cognitive measures used in the study and statistical methods applied for analysis

OUTCOME(S) TO
BE PREDICTED

Was the same outcome definition (and method for measurement) used in all patients?
Calibration: Goodness of fit/ Hosmer-Lemeshow test- agreement between observed outcomes and
predictions
Discrimination: AUC
Clinical utility: Sensitivity, specificity, positive/negative predictive values, OR’s, relative risk, AUC or
clinical utility curve noting model cut off values
IF any cognitive assessments and predictive variable use per model.
Type of outcome (e.g., single or combined endpoints)
Data extraction and comparison between tools- is there 23 or 27 models?
The average NOS quality ranking for included cohort studies was seven; six studies received the
maximum of nine stars. Risk of bias was assessed using the CHARMS checklist,
Was the outcome assessed without knowledge of the candidate predictors (i.e., blinded)?
No mention of blinding
Were candidate predictors part of the outcome (e.g., in panel or consensus diagnosis)? No, the
candidate predictors were not part of the outcome of this review, this review focused on content of
each study
Time of outcome occurrence or summary of duration of follow-up

1

2

2

2

2
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No follow up needed in this study as they were evaluating studies for recommendations for future
studies.
Number and type of predictors (e.g., demographics, patient history, physical examination, additional
testing, disease characteristics)
1. outcome measure (method to dx, frequency and length of follow up)
2. diagnostic accuracy of the delirium prediction models, calibration metrics and events per
variable (EPVs)
3. characteristics which included variables used in model and stratification system, cognitive measures
used in the study and statistical methods applied for analysis
Definition and method for measurement of candidate predictors

CANDIDATE
PREDICTORS
(OR INDEX TESTS)

Outcomes measures:
Characteristics of studies were reported and compared, as was tool to dx delirium, Model design or
statistical methods, variables used in each study (most common Pre-existing impaired cognition,
sensory impairment, old age, impair ADL’s, Illness severity, Infection, history of alcohol use,
Predictive ability: reported as the AUC with a table showing each
Model calibration: Chi-square statistics and if they had calibration plots or slopes
EVPs to determine overfitting-Models estimating more parameters than events in a 1:10 ratio are at
risk of statistical overfitting, potentially leading to overly optimistic model performance
Clinical Utility: OR’s, RR, Sensitivity and specificity, ROC curves, R² and integrated discrimination
improvement indices as well as the clinical utility curve statistic and the decision curve analysis

2

3-16

Timing of predictor measurement (e.g., at patient presentation, at diagnosis, at treatment initiation)
Note discussed as each of these are measured within each study. Predictors not critically evaluated in
this systematic review.
Were predictors assessed blinded for outcome, and for each other (if relevant)? NA-Not relevant

SAMPLE SIZE

Handling of predictors in the modelling (e.g., continuous, linear, non-linear transformations or
categorized) NA- not relevant
Number of participants and number of outcomes/events
27 or 23 studies were reviewed, medical and surgical included, all had 50 or more for the same size to
prevent overfitting.
Number of outcomes/events in relation to the number of candidate predictors (Events Per Variable)
Varied between each study

2
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MISSING DATA

Number of participants with any missing value (include predictors and outcomes)
Each study reported their own missing data; however, this study did not comment on this which would
be a benefit to recommend how to deal with missing data for future studies
Number of participants with missing data for each predictor-NA
Handling of missing data (e.g., complete-case analysis, imputation, or other methods)-NA
Modeling method (e.g., logistic, survival, neural network, or machine learning techniques)
Model design and methods between the models were compared and they noted how many studies used
which techniques i.e.: 12 used univariate or bivariate analyses, 5 of these used bootstrapping
technique to address low sample size and event size. Noted it was common to have narrow validation
studies, in which external validation is needed for risk of bias is possible.

Not
addressed
NA
NA
4-5

Modelling assumptions satisfied-N/A
MODEL
DEVELOPMENT

MODEL
PERFORMANCE

MODEL
EVALUATION

Method for selection of predictors for inclusion in multivariable modelling (e.g., all candidate
predictors, pre-selection based on unadjusted association with the outcome)
This review does not create a model it simply recommends inclusions for future research
Newcastle Ottawa Scale was used to determine quality ranking
Method for selection of predictors during multivariable modeling (e.g., full model approach,
backward or forward selection) and criteria used (e.g., p-value, Akaike Information Criterion)
This was compared between models included in this study
Shrinkage of predictor weights or regression coefficients (e.g., no shrinkage, uniform shrinkage,
penalized estimation) N/A
Calibration (calibration plot, calibration slope, Hosmer-Lemeshow test)
Discrimination (C-statistic, D-statistic, log-rank, AUROC) measures with confidence intervals
Discussed in context of combined models, Table B9 is a comparison of the AUROC for each model
included. Provides a nice visual comparison
Classification measures (e.g., sensitivity, specificity, predictive values, net reclassification
improvement) and whether a-priori cut points were used
Discussed in context of combined models
Method used for testing model performance: development dataset only (random split of data,
resampling methods e.g. bootstrap or cross-validation, none) or separate external validation (e.g.
temporal, geographical, different setting, different investigators)

3-16

NA

NA

17
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Discussed in context of combined models- model performance was assessed through calibration and
classification metrics
Clinical utility statistics such as sensitivity, specificity, positive predictive values, negative predictive
values, ORs, relative risk statistics and use of decision curve analysis or clinical utility cure analysis
were also collected from each delirium prediction model in reference to the model’s reported cut-off
value.
TP
FP
FN

TN

with delirium total

Without delirium

In case of poor validation, whether model was adjusted or updated (e.g., intercept recalibrated,
predictor effects adjusted, or new predictors added)
NA

RESULTS

Not discussed, though would be important to discuss for future research recommendations.
Final and other multivariable models (e.g., basic, extended, simplified) presented, including predictor
weights or regression coefficients, intercept, baseline survival, model performance measures (with
standard errors or confidence intervals)
This was also not discussed but pertinent to future research when creating or assessing usability of
these prediction models.
Any alternative presentation of the final prediction models, e.g., sum score, nomogram, score chart,
predictions for specific risk subgroups with performance; NA

Comparison of the distribution of predictors (including missing data) for development and validation
datasets
Missing data not discussed
Interpretation of presented models (confirmatory, i.e., model useful for practice versus exploratory,
i.e., more research needed)
INTERPRETATION1. moderate predictive ability (AUROC 0.52–0.94) in 14 externally validated delirium prediction models
AND DISCUSSION
with 8 out of 14 models using narrow validation

NA

NA

NA
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Comparison with other studies, discussion of generalizability, strengths and limitations.
Limitations: Study design, application and reporting of statistical methods appear inadequate, low
EPV result in overfitting and over optimism of the tools and increase risk of bias.
Variable definitions too broad: functional and cog abilities- overlap data.
And last the outcome variable, delirium, was largely non-systematic frequency of measurement ranged
based on time of day and was avoided weekends- delirium is fluctuating and requires increased
screening.
Generalizability: each model tends to focus on a specific population and is difficult to generalize to all
populations, some studies are also focused on prevalent vs incident delirium
Strengths: interprofessional team, multiple perspectives for recommendations for future studies.
Systematic review that was prospectively developed. Comprehensive literature search was completed.
This is the first to identify study and model design issues and discusses the paucity of measurements
sensitive to the spectrum of cognitive impairment.
Implications for future research:
1. Model aggregation
2. Develop and broad validation simplifying cognitive tests that would include MCI and be
sensitive to cognition
3. Develop dynamic models using Bayesian Networks, artificial intelligence, machine learning
4. Build predictors based on only data available prior to delirium onset
5. Twice daily assessments of delirium-screen
6. Include variables that are commonly available in clinical practice
7. Follow rigorous methods outlined by Steyerberg and Vergouwe that allow for strategies to
counter low EPV, use of Akaike info criterion and Bayesian information criterion to assess
model fit.
8. Broad Validation
9. Adhere to TRIPOD for reporting methods.
10. Focus on building two models, one elective and one emergent.
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Domain

Key items

SOURCE OF DATA
“PREDICTING
DELIRIUM: A REVIEW
OF RISKSTRATIFICATION
MODELS”
Newman et al., 2015

Source of data (e.g., cohort, case-control, randomized trial participants, or registry data):
PubMed MEDLINE (1940-present), EMBASE (1947- present), PsychINFO (1800-present),
CINAHL (1981-present), and Cochrane since inception. NO date or language exclusions for
studies through December 5 2013. Grey literature search also completed on studies found.
PRISMA flow diagram included on pg. 409

page #

408-9

AIM: review studies of validated risk stratification models and discuss barriers to use and
future research directions. Qualitative study.

PARTICIPANTS

OUTCOME(S) TO BE
PREDICTED

Participant eligibility and recruitment method (e.g., consecutive participants, location, number
of centers, setting, inclusion and exclusion criteria)
Inclusion: Original research, adult population, acute medical inpatients and presence of
validation. 10 articles met this criteria and were included.

409

Participant description- participants here are studies of development and validation of risk
prediction models for delirium in the hospital setting
Inclusion: 10 studies were included, and quality assessed by a modified version of the
Newcastle Ottawa Scale for cohort studies, noting that due to nature of the research papers
they discounted 2 of the scores so that the highest rating is 7 not 9.
Details of treatments received, if relevant-NA

410

Study date retrospective literature review, inception to Dec. 5th 2013

408

Definition and method for measurement of outcome
Outcomes in this study were: Variables Extracted: each studies variables, risk-stratification
model- linear vs otherwise, All models tested on a validation cohort, population, delirium
outcome assessment tool, risk factors included in prediction model, model structure, statistics
typically AUC LR OR or %, and compared to the validation cohort.

410
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Was the same outcome definition (and method for measurement) used in all patients?
Outcome tool was listed and compared for each assessment model
The outcome of this systematic review is for research in the future and identify barriers for
implementation.
Type of outcome (e.g., single or combined endpoints)
Review and compare models, find barriers
Was the outcome assessed without knowledge of the candidate predictors (i.e., blinded)?
No mention of blinding
Were candidate predictors part of the outcome (e.g., in panel or consensus diagnosis)? No, the
candidate predictors were not part of the outcome of this review, this review focused on content
of each study, though they were discussed and compared in a table form.
Time of outcome occurrence or summary of duration of follow-up
No follow up needed in this study as they were evaluating studies for recommendations for
future studies.

CANDIDATE
PREDICTORS
(OR INDEX TESTS)

Number and type of predictors (e.g., demographics, patient history, physical examination,
additional testing, disease characteristics)
4. Each predictor was discussed and noted to be included in how many of the studies included out
of 10. Age, Illness severity, Cognitive impairment, BUN, ADL impairment, Model performance
(validation cohorts less AUC than development), AUCs were compared, Carrasco tested +LR
and -LR. Use in clinical practice was also a topic-noting no model was found to be actively
used in clinical practice.
Definition and method for measurement of candidate predictors
Outcomes measures: AUC or LRs
Timing of predictor measurement (e.g., at patient presentation, at diagnosis, at treatment
initiation)
8/10 used clinical data available at time of admission to predict subsequent delirium
Were predictors assessed blinded for outcome, and for each other (if relevant)? NA-Not relevant
Handling of predictors in the modelling (e.g., continuous, linear, non-linear transformations or
categorized) Noted that most handled them linearly

408
408

410
NA

411-412

412

410
NA
410
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SAMPLE SIZE

MISSING DATA

Number of participants and number of outcomes/events
10 models included. AUC/C-statistic/LRs compared. This study did not reveal rates of delirium
in each study or % of positive prediction
Number of outcomes/events in relation to the number of candidate predictors (Events Per
Variable) This study did not discuss EPV which would be a significant finding as EPV is
essential to building prediction modeling
Number of participants with any missing value (include predictors and outcomes)
Each study reported their own missing data; however, this study did not comment on this which
would be a benefit to recommend how to deal with missing data for future studies
Number of participants with missing data for each predictor-NA
Handling of missing data (e.g., complete-case analysis, imputation, or other methods)-NA

410

NA

Not
addressed
NA
NA

Modeling method (e.g., logistic, survival, neural network, or machine learning techniques)
Model design and population, delirium assessment, risk factors all compared. The specific
model development methods were not discussed in this review.
Modelling assumptions satisfied-N/A

MODEL DEVELOPMENT

Method for selection of predictors for inclusion in multivariable modelling (e.g., all candidate
predictors, pre-selection based on unadjusted association with the outcome)
This review does not create a model it simply recommends inclusions for future research
Newcastle Ottawa Scale was used to determine quality ranking
Method for selection of predictors during multivariable modeling (e.g., full model approach,
backward or forward selection) and criteria used (e.g., p-value, Akaike Information Criterion)
This was not discussed
Shrinkage of predictor weights or regression coefficients (e.g., no shrinkage, uniform shrinkage,
penalized estimation) N/A

410

NA

NA
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Calibration (calibration plot, calibration slope, Hosmer-Lemeshow test)
Discrimination (C-statistic, D-statistic, log-rank, AUROC) measures with confidence intervals
Discussed in context of combined models, table B9 compares AUC and other statistics

410

MODEL PERFORMANCE
Classification measures (e.g., sensitivity, specificity, predictive values, net reclassification
improvement) and whether a-priori cut points were used
These were not mentioned in this study, which is a significant limitation to this study if they are
looking for clinical limitations

MODEL EVALUATION

Method used for testing model performance: development dataset only (random split of data,
resampling methods e.g. bootstrap or cross-validation, none) or separate external validation
(e.g. temporal, geographical, different setting, different investigators)
Discussed in context of combined models- model performance evaluated by AUC or LRs.
Clinical utility statistics such as sensitivity, specificity, positive predictive values, negative
predictive values, ORs, relative risk statistics were not discussed.
In case of poor validation, whether model was adjusted or updated (e.g., intercept recalibrated,
predictor effects adjusted, or new predictors added)
Noted validation studies decreased in AUC, poor to good accuracy.

RESULTS

Final and other multivariable models (e.g., basic, extended, simplified) presented, including
predictor weights or regression coefficients, intercept, baseline survival, model performance
measures (with standard errors or confidence intervals)
This was also not discussed but pertinent to future research when creating or assessing
usability of these prediction models.
Reasons for lack of implementation is cited as: complex or time consuming, variables difficult
to measure on admission like the APACHE II, additional cognitive tests if not done right may
incorrectly diagnose. Intensive staff education would be needed to implement, compliance
teams to follow, and assessing reliability.
Any alternative presentation of the final prediction models, e.g., sum score, nomogram, score
chart, predictions for specific risk subgroups with performance; NA

412

NA

412

NA
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Comparison of the distribution of predictors (including missing data) for development and
validation datasets Missing data not discussed

NA

Interpretation of presented models (confirmatory, i.e., model useful for practice versus
exploratory, i.e., more research needed)
2. moderate predictive ability (AUROC 0.52–0.94) in 14 externally validated delirium prediction
models with 8 out of 14 models using narrow validation

Comparison with other studies, discussion of generalizability, strengths and limitations.

INTERPRETATION AND
DISCUSSION

Limitations: possible to miss some relevant studies. Studies may have been incorrectly screened
out; this is a qualitative review thus no attempt to pool data from the studies.
Strengths: First study of its kind, comparing quality and defining reasons for lack of
implementation in clinical practice. Notes future focuses for research.
They noted the heterogeneity of results and methods used to develop the models and use of risk
factors.
Implications for future research: Replicate results of current studies and compare them,
develop new prediction tools focusing on fast reliable assessments with well-supported risk
factors.
Future hope: Lower cost of care and decreased mortality may be a result of timely
identification, prevention, and treatment of delirium.

412
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Domain

page #

Key items
Source of data (e.g., cohort, case-control, randomized trial participants, or registry data):

SOURCE OF DATA:
“Models for Predicting
Incident Delirium in
Hospitalized Older Adults: A
Systematic Review”
Kalimisetty et al., 2017

PARTICIPANTS

Medical librarian customized and conducted a search for all published medical articles on
delirium prediction models. Ovid MEDLINE, CINAHL, Cochran Database of systematic
Reviews, EMBASE, and PsycINFO were searched using PICO- based inquiry. Terms used
were variants of delirium, AMS, Acute confusional stated Acute brain syndrome, acute brain
failure metabolic encephalopathy, predict, predictive, models, modeling, scores, tests testing,
scoring, rules, index, and indices. Grey literature review was also completed.
AIM: Summarize risk prediction models and identify the most prevalent factors of incident
delirium in the older in-patient populations (65 or greater), for future build of a risk prediction
model to be used by the Hospital Elder Life Program (HELP) to reduce incident delirium cases.
Participant eligibility and recruitment method (e.g., consecutive participants, location, number
of centers, setting, inclusion and exclusion criteria)
Inclusion: PRISMA Guidelines used. English language only, older population, original
research to development models with derivation and validation cohorts. excluded systematic
reviews and meta-analysis. 12 articles included.
Participant description- participants here are studies of development and validation of risk
prediction models for delirium in the hospital setting
Inclusion: 12 studies were included, and quality assessed by a modified version of the
Newcastle Ottawa Scale for cohort studies, original scale of 1-9 was used
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Details of treatments received, if relevant-NA
Study date Dates not noted, nor noted in inclusion criteria
OUTCOME(S) TO BE
PREDICTED

Definition and method for measurement of outcome
Variables Extracted: study description, population, delirium assessment method, incidence of
reported delirium rate, and risk factors for delirium
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Was the same outcome definition (and method for measurement) used in all patients?
Quality was defined as the NOS scale.
All other variables were defined equally
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Type of outcome (e.g., single or combined endpoints)
Single endpoints, all compared in tables.

70-4

Was the outcome assessed without knowledge of the candidate predictors (i.e., blinded)?
No mention of blinding-NA
Were candidate predictors part of the outcome (e.g., in panel or consensus diagnosis)? Yes, this
study was assessing what predictors commonly are used in the RPMs. Comparative table on
page 74 – 75 listing all the co-efficient and statistics of each predictor.
Time of outcome occurrence or summary of duration of follow-up
No follow up needed in this study as they were evaluating studies for recommendations for
future studies.
Number and type of predictors (e.g., demographics, patient history, physical examination,
additional testing, disease characteristics)
5. All candidate predictors were compared that were found in the studies (20)

CANDIDATE
PREDICTORS
(OR INDEX TESTS)

SAMPLE SIZE

74
NA

74

Definition and method for measurement of candidate predictors
Outcomes measures: RR, OR, B, HR (hazard ratio), SE (standard errors)
Noting the most common risk factors used dementia, decreased functional status, high blood
urea nitrogen-to-creatinine ratio, infection and severity of illness

74-5

Timing of predictor measurement (e.g., at patient presentation, at diagnosis, at treatment
initiation) Any time during admission
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Were predictors assessed blinded for outcome, and for each other (if relevant)? NA-Not relevant
Handling of predictors in the modelling (e.g., continuous, linear, non-linear transformations or
categorized) Uncertain as the models and stratification levels were not a focus in this review
Number of participants and number of outcomes/events
12 models compared for predictors. Aim was also to summarize models, the only summary
done was comparing retro vs prospective and the predictors
Number of outcomes/events in relation to the number of candidate predictors (Events Per
Variable) This study did not discuss this.

NA
NA
70

NA

100

MISSING DATA

Number of participants with any missing value (include predictors and outcomes)
Not addressed
Number of participants with missing data for each predictor-NA
Handling of missing data (e.g., complete-case analysis, imputation, or other methods)-NA
Modeling method (e.g., logistic, survival, neural network, or machine learning techniques)
Model design and population, delirium assessment, risk factors all compared. The specific
model development methods were not discussed in this review.

MODEL DEVELOPMENT

NA
NA
NA
NA

Modelling assumptions satisfied- N/A

NA

Method for selection of predictors for inclusion in multivariable modelling (e.g., all candidate
predictors, pre-selection based on unadjusted association with the outcome)
This review does not create a model it simply reviews predictors used in RPM for a future build
of an RPM for use with HELP interventions
Newcastle Ottawa Scale was used to determine quality ranking
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Method for selection of predictors during multivariable modeling (e.g., full model approach,
backward or forward selection) and criteria used (e.g., p-value, Akaike Information Criterion)
This was not discussed

NA

Shrinkage of predictor weights or regression coefficients (e.g., no shrinkage, uniform shrinkage,
penalized estimation) N/A

NA

Calibration (calibration plot, calibration slope, Hosmer-Lemeshow test)
Discrimination (C-statistic, D-statistic, log-rank, AUROC) measures with confidence intervals
Discussed in context of combined models, table 4 compares statistics of the specific predictors

74-5

MODEL PERFORMANCE
Classification measures (e.g., sensitivity, specificity, predictive values, net reclassification
improvement) and whether a-priori cut points were used
These were not mentioned in this study, as they were looking for predictors and to summarize
the current models
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MODEL EVALUATION

Method used for testing model performance: development dataset only (random split of data,
resampling methods e.g. bootstrap or cross-validation, none) or separate external validation
(e.g. temporal, geographical, different setting, different investigators)
Not discussed.
In case of poor validation, whether model was adjusted or updated (e.g., intercept recalibrated,
predictor effects adjusted, or new predictors added)
Noted that these models were scored based on the NOS and noted to be fair to good rating.

RESULTS

INTERPRETATION AND
DISCUSSION

Final and other multivariable models (e.g., basic, extended, simplified) presented, including
predictor weights or regression coefficients, intercept, baseline survival, model performance
measures (with standard errors or confidence intervals)
NA
Any alternative presentation of the final prediction models, e.g., sum score, nomogram, score
chart, predictions for specific risk subgroups with performance; NA
Comparison of the distribution of predictors (including missing data) for development and
validation datasets Missing data not discussed, comparison of predictors was the aim of this
study.
Interpretation of presented models (confirmatory, i.e., model useful for practice versus
exploratory, i.e., more research needed)
Very little data summarized for these RPM, the aim was to summarize them however the only
summary given was a comparison of how many studies were prospective vs retrospective, rates
of delirium, number of risk factors included in each was 2-6, and the most/least common risk
factors.

412

72

NA

NA
70-5
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Comparison with other studies, discussion of generalizability, strengths and limitations.
Limitations: variation in the studies in the way they assessed for delirium. Decreased NOS due
to studies did not include follow up data. Varied incidence of delirium between retrospective
and prospective cohorts (common finding to be less rated as delirious in a retrospective study).
Strengths: consistent with previous research on predictors-high number of predictors compared
to study numbers (delirium is multifactorial in nature).
Implications for future research: application of these predictive variables to a future tool for
implementation with HELP interventions, making an automated tool to be used in the EMR.
Future hope: The authors noted that they have already implemented a tool to mark pt. as at risk
for delirium based on the Acute Care for Elders Tracker (ACE). However, the risk factors for
HELP may not be the best sued in the HER due to missing data. Use of the HER with simplified
variables may aid in more accurate RPMs.
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Table 14
Statistical Comparison of the Validated Delirium Risk Prediction Models
Study

∆£≠œ: Type
of study

Validation
Sample
Martinez,
2012
Clinical
prediction
rule for
delirium

£
n = 302
Mean age=
76.8
Medical

Delirium
diagnosis
(identified
by)
CAM-s
(researche
rs)

Delirium
cases
identified
76
(25.5%)
Incident

Risk factors
included in
the tool
(weighting)
•Age ≥85
†DADLs
*Drugs
1 point each
Cut off ≥1

Modelling
approach/
Discrimination
values
Regression
AUC 0.85
(0.80-0.90)
Se=93.4%
Sp=60.6%
PPV=44.4%
NPV=96.5%

Reported
risk
levels

Observed delirium cases, by
risk level

Discrimination
and events per
variable (EPV)

0 Factors
1 Factor
≥2
Factors

3.5% (5/142)
23% (18/77)
64% (53/83)

EPV 25

Writer conclusions made:
44.4% with a score of ≥1 or
high risk, developed delirium
and only 7% of those low risk
developed delirium
Limiting interventions to 53%
of this population, making
rationing interventions possible

104

Study

∆£≠œ: Type
of study

Validation
Sample
Douglas,
2013
The AWOL
Tool

£
n=165
Mean age
=70.72
Medical
/Neuro
Time=<2
minutes

Delirium
diagnosis
(identified
by)
CAM-s
(physicia
ns)

Delirium
cases
identified
14 (8%)
Incident

Risk factors
included in
the tool
(weighting)
Age ≥80
¡WORLD
Orientation
RN rated
Severity of
illness
1 point each
Cut off ≥2

Modelling
approach/
Discrimination
values
Logistic
Regression
AUC 0.69
(0.54-0.83)

Reported
risk
levels

Observed delirium cases, by
risk level

Discrimination
and events per
variable (EPV)

0 Factors
1 Factor
2 Factors
3 Factors
4 Factors

4% (1/25)
3% (2/59)
10% (5/49)
21% (6/28)
0% (0/4)

EPV 3.5

Writer Conclusions made:
78% of those dx with delirium
were correctly categorized as
elevated risk, thus 21% of those
with delirium would have been
missed and not included in the
intervention group.
Interventions would be limited
to 81 out of 165 or 49% of the
total population making risk
stratification possible.
Including all the factors 1 or
more would include 99% of all
delirious but increase the
number treated to 140, which is
nearly 85% of the population
making triaging less effective.
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Study

∆£≠œ: Type
of study

Validation
Sample
Kobayashi, et
al., 2013
CHAID

£
N=1170
Mean
age=78.5
delirious
and 64.8 no
delirium
Medical

Delirium
diagnosis
(identified
by)
DMS IV
TR
(physicia
n)

Delirium
cases
identified
51
(4.4%)
Incident

Risk factors
included in
the tool
(weighting)
Delirium hx
Age
Underlying
malignancy
ADL
impairment

Modelling
approach/
Discrimination
values
Chi Square
AUC 0.82
(0.76-0.88)

Reported
risk
levels

Observed delirium cases, by
risk level

Discrimination
and events per
variable (EPV)

0 Factors
1 Factor
2 Factors
3 Factors
4 Factors
5 Factors

0.0%
1.8%
1.5%
2.5%
9.4%
46.4%

EPV 10.2

Writer Conclusions: this is an
algorithm, thus those in
moderate to high risk would be
those you would focus
interventions on. 1170 pts
included; 51 cases identified. If
scoring included factors 3-5
only approx. 3% of cases would
be missed. (factors 0-2). Of
note zero patients with a zero
score were delirious and the
highest % delirious were
included in all 5 factors!
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∆£≠œ: Type
of study

Validation
Sample
Rudolph,
2016
E-NICE Rule
A separate
look at e-Nice
plus mRASS

£
N=246
Mean
age=72.1
(E-NiceTime 8
seconds
Electronical
ly)
Medical
Added m

Delirium
diagnosis
(identified
by)
DSM IV
TR
Geriatric
physician

Delirium
cases
identified
43
(19%)
Incident

Risk factors
included in
the tool
(weighting)
Cognitive
Impairment
4
Age≥65 2
Age>80 3
Fracture 4
Vision 1
Severe
illness 2

Modelling
approach/
Discrimination
values
Chi Square and
Rank Sum
AUC 0.68
(0.59-0.77)
+mRASS=
AUC 0.72

Reported
risk
levels

Observed delirium cases, by
risk level

Discrimination
and events per
variable (EPV)

0-2 score
3-5 score
6-8 score
≥9 score

10.4% (10/96)
14.3% (6/42)
23% (13/55)
43.8%(14/32)

4= EPV 16

add score
(mRASS
added)

If you increase this to include
positive mRASS would increase
# to treat to 108 with 40.7%
delirium positive and TMYB #
to treat is 127 with 39.4%
delirium positive.
But if you drop the rate to
include a score of ≥3 you
capture 33 delirious out of 129
or 25.5% delirious rate and
treating 129/246 or 52.4% of the
total of people. Which is still
allowing for triaging and
allocation limitations but is
decreasing those at risk that are
missed.
I recommend dropping the score
to 3 or more.

5= EPV 12.8
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∆£≠œ: Type
of study

Validation
Sample
Pendlebury
2016a
External
validation
and update of
DRPM’s

œ
N=308
Mean
age=81
Medical

Delirium
diagnosis
(identified
by)
CAM
DSM IV

Delirium
cases
identified
28
(9.1%)
Incident

Risk factors
included in
the tool
(weighting)
Inouye 1993
updated
Vision
SIRS≥2
MMSE<24
BUN/Cr rat.
Martinez,
2012
Updated
Age≥85
∑Functional
dependence
Psychotropic
* drugs
Isfandiaty
Cognitive
impairment
Functional
dependency
Infection no
sepsis/w
sepsis
Douglas2013
Age≥80
WORLD
ΩDisorienta
ted to place
RN-Illness
severity

Modelling
approach/
Discrimination
values
Inouye 1993
updated
AUC=0.73
(0.62-0.84)
Martinez, 2012
AUC= 0.78
(0.68-0.88)

Isfandiaty
AUC=0.83
(0.74-0.91)

Douglas 2013
AUC=0.78
(0.68-0.88)

Reported
risk
levels

Observed delirium cases, by
risk level

Discrimination
and events per
variable (EPV)
Martinez EPV
9.33

1 Factor
2 Factors
3 Factors

Se, Sp, ppv, npv
.95, .34, .19, .98
.52, .80, .31, .91
.14, .96, .38, .87
(unreported)
Se, Sp, ppv, npv
.95, .36, .19, .98
.81, .68, .29, .96
.38, .88, .35, .90

1 score
2 score
3 score
4 score
5 score
6 score
7 score

Se, Sp, ppv, npv
1.0, .34, .20, 1.0
.95, .43, .21, .98
.90, .55, .25, .97
.81, .71, .31, .96
.57, .77, .29, .92
.48, .95, .59, .92
.33, .93, .44, .90

1 Factor
2 Factors
3 Factors
4 Factors

Se, Sp, ppv, npv
.95, .18, .16, .96
.95, .66, .27, .94
.76, .66, .27, .94
.27, .93, .70, .68

1 Factor
2 Factors
3 Factors
4 Factors

Writer conclusion:
lower NPV and higher Sp than
it is to have a high PPV or low
Se because including more
patients in risk levels that MAY
develop delirium is imperative
to prevention.

All other
studies
EPV 7
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∆£≠œ: Type
of study

Validation
Sample
Pendlebury
2016b
Delirium
Screening
Score (DSS)

£
N=308
Mean
age=81
Medical

Delirium
diagnosis
(identified
by)
CAM
DSM IV

Delirium
cases
identified
28
(9.1%)
Incident

Risk factors
included in
the tool
(weighting)
AGE ≥80 2
≈Cognitive
Impairment2
SIRS ≥2 1
Infection 1
Vision
impairment 1
(Based on
UK NICE
guidelines
and previous
comparison
study above)

Modelling
approach/
Discrimination
values
AUC 0.81
(0.70–0.92)

Reported
risk
levels

1 score
2 score
3 score
4 score
5 score
6 score
7 score

Observed delirium cases, by
risk level

Discrimination
and events per
variable (EPV)

Se, Sp, ppv, npv
1, .17, .16, 1
.95, .19, .16, .96
.86, .49, .21, .95
.81, .61, .25, .95
.71, .88, .50, .95
.29, .95, 0.5, .89
0, 1, 1, .86

EPV (28/5) =
5.6

Writer conclusion: this is a wellresearched study with a very high
AUC. The risk stratification
levels correlate well with the
actual diagnosed cases of
delirium. Well researched risk
factors contribute to the high
accuracy of this test. This was a
second study based on the same
population as of their update
model study 2016a. This model
out preforms the others, as they
learned much from the previous
study and previous DRPMs.
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∆£≠œ: Type
of study

Validation
Sample
Carrasco,
2014
Delirium risk
prediction
score

£
N=104
Mean
age=75.5
Medical

Delirium
diagnosis
(identified
by)
CAMSpanish
version

Delirium
cases
identified
12
(11.7%)
Incident

Risk factors
included in
the tool
(weighting)
Bun Creatine
ratio
Barthel
index
DPS
Equation:
(1370 X
BUN
(mmol/l)/cre
atine
(µmol/l)
ratio)- 4 X
Barthel
Index)
Cut off -240
Or
conventional
units
DPS= [5X
BUN
(mg/dl)/creat
inine
(mg/dl)} –(3
X Barthel
index)
Cut off -160

Modelling
approach/
Discrimination
values
AUC 0.78
(0.66-0.90)

Reported
risk
levels

Observed delirium cases, by
risk level

Discrimination
and events per
variable (EPV)

>-240

Sp-0.74
Se-0.88
NPV- 0.99

EPV 4

Writer conclusion:
So, 99% of those that test
negative do not develop
delirium, thus including more of
those at truly high risk. Here
out of 104 people
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∆£≠œ: Type
of study

Validation
Sample
Wong, 2018
Machine
learning
models

£
N=3996
Mean age=
Medical

Four
electronic
tools
compared

Computeriz
ed scoring.
Automated,
based on
chart data

Delirium
diagnosis
(identified
by)
Nu-DESC
CAMICU

Delirium
cases
identified
191
(4.8%)

Risk factors
included in
the tool
(weighting)
AWOL risk
factors as
stated above
in table
Hundreds of
risk factors
for each e
learning
program.
GBM-345
LR- 111
RF- 114

Modelling
approach/
Discrimination
values
Penalized
logistic
regression

Reported
risk
levels

AWOL AUC0.678
SE- 32.8% SP90.5%
GBM-AUC
0.855

4 Factorssee above
AWOL

Observed delirium cases, by
risk level

Discrimination
and events per
variable (EPV)

Writer conclusion: easy to
adjust the Se and Sp to your
desired levels for these machine
learning tools.
Higher Sp and lower NPV
would be the goal in order to
balance interventions with less
misses of those that do develop
delirium. This method would
also be flexible enough to
continue to modify these values
based on data obtained during
say a QI project or external
validation study.

AWOL EPV-20
Unable to
calculate others
as it is not
directly stated
the number of
predictors used.

Risk
levels
determine
Logistic
d by
regression
setting
model AUCsensitivity
0.854
and
specificit
Random Forest y within
AUC-0.843
the
computer
models.
1 Note. ∆£≠œ Type of study: ∆ Development and validation on same cohort, £ Development and validation using a different cohort, ≠ Validation only, Œ Model
update with validation
• Age ≥85
† DADLs: dependence in five or more activities of daily living
* Drugs prescribed prior to admission, one point for antidepressants, antidementia, and anticonvulsants and two points for antipsychotics
¡ Ability to spell WORLD backwards
∑ researchers assess patient in six activities of daily living
Ω replaced by dx of dementia or cognitive score cut-off point
≈ MMSE

